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1. SUMMARY OF THE STUDY 
Biological interactions due to electromagnetic fields (EMF) have been reported 
over nearly the entire range of frequencies, field strengths and amplitudes 
occurring in the natural and man-made environments, and it is certain that the 
wide range of biological effects observed is governed by a variety of distinct 
mechanisms [Funk et al., 2009]. Environmental exposure to a wide range of 
EMFs has increased substantially in recent years, motivating a large and growing 
body of research. Questions regarding the health effects of power line fields 
oscillating at 50-60 Hz with amplitudes in the mT range were raised more than 30 
years ago [Wertheimer et al., 1979]. Although the present controversy over GSM 
mobile phone exposure and cancer is ongoing [Kundi, 2009], public health 
concerns are reflected by the recent classification (31 May, 2011) by the 
International Agency for Research on Cancer of radiofrequency EMFs from 
mobile phone use as possibly carcinogenic to humans. Of particular interest to 
neuroscience is the possibility of EMF effects on neural functioning and 
neurodegenerative diseases [Cook et al., 2002, 2006; Consales et al, 2012], and a 
recent conference, Neurodegenerative Diseases and ELF & RF EMF Exposure, 
hosted by the Italian National Agency for New Technologies, Energy and 
Sustainable Economic Development (Berlin, 20th-21st September 2011), helped 
to establish strategies for in vitro and in vivo research. Ongoing concerns 
regarding health risks of EMF exposure led to the release of the BioInitiative 
Report, A Rationale for a Biologically-based Public Exposure Standard for 
Electromagnetic Fields (ELF and RF) [published online: www.bioinitiative.org, 
31 August, 2007]. This 610-page report was written by 14 prominent scientists, 
public health and public policy experts to document the scientific evidence on 
health effects of electromagnetic fields and subjected to review by another dozen 
outside reviewers. The BioInititative Report provides a review of bioeffects and 
reports of health risks occurring at very low exposure levels (non-thermal levels 
of extremely low frequency (ELF) and radiofrequency EMF and has made several 
recommendations urging the immediate reduction of current public exposure 
limits. However, in contrast to public alarm regarding long-term hazards, a body 
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of double-blind placebo-controlled studies report therapeutic effects for a variety 
of types of short-term EMF exposures [Pilla, 2006] and these modalities are 
approved for clinical use to reduce pain and edema, and enhance bone and wound 
repair. Also, recent studies have reported GSM treatment to be neuroprotective 
and to reverse cognitive impairment in an Alzheimer’s disease mouse model 
[Arendash et al., 2010, 2012]. 
 
Although the discussion regarding health risks and benefits is ongoing, it is clear 
that neurological effects due to a wide range of subthreshold EMFs do in fact 
occur [Cook et al., 2002, 2006], and that further research is required to establish 
the mechanisms of action, and to assess safety and potential harm. Reports of 
EMFs bioeffects of particular interest to the neurosciences include brain cancers 
[Repacholi et al., 2012], oxidative stress and neurodegeneration [Consales et al., 
2012], the effects of radiofrequency fields [van Rongen et al., 2009], cognitive 
effects [Cook et al., 2002, 2006] and psychotherapeutic potential [Pooley, 2010]. 
While reports of both injurious and therapeutic EMF bioefects continues to 
accrue, uncertainty remains regarding the basic mechanism of many of the above 
observed effects. Some bioeffects due to microwave and radiofrequency 
exposures can be directly attributed to EMF-induced heating of biological tissues 
[Lin, 2004, Chou, 2006], and a large body of evidence has conclusively 
demonstrated that also nonthermal EMFs, which can be shown to produce no 
heating of the biological target, have a variety of biological effects [Funk et al., 
2009]. One promising line of research has been motivated by in vitro evidence 
suggesting pathways mediated by ion binding as common targets using 
nonthermal EMF signals. Nonthermal bioeffects on ion binding systems have 
been demonstrated using a variety of EMF configurations. Among these are: static 
(DC) and extremely low frequency (ELF) alternating (AC) magnetic fields, 
configured such that heating due to the induced electric field is negligible, and 
radiofrequency fields configured using pulse-modulation techniques to yield with 
low duty cycles and negligible levels of heating. The first speculations that ion 
and ligand binding may serve as the primary transduction pathways for DC and 
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ELF magnetic field effects were suggested by observations of effects on Ca2+ 
binding and efflux [Bawin et al., 1975, 1976; Blackman et al. 1982]. Subsequent 
studies on Ca2+-calmodulin (CaM)-dependent phosphodiesterase [Bull et al., 
1993, Liboff et al., 2003] and myosin phosphorylation [Shuvalova et al., 1991; 
Markov et al., 1992, 1994, 1997] suggested sensitivity to static and time-varying 
magnetic fields and also to pulse-modulated radiofrequency (PRF) signals. A 
report of Ca2+-dependence of these effects further suggested Ca2+/CaM binding as 
a possible primary EMF transduction pathway [Markov et al., 1997]. In the light 
of this experimental evidence, several of my previous biophysical models 
[Muehsam et al., 1994, 1996, 1999, 2009a, 2009b] and collaborations [Pilla et al., 
2011] were concerned primarily with the mechanisms of action of EMFs on ion 
binding pathways.  
 
The primary goals of this study were to develop a neurologically-relevant cell-free 
in vitro assay for the assessment of nonthermal EMF bioeffects and to develop 
theoretical models in accord with current experimental observations. A 
Ca2+/CaM-dependent nitric oxide (NO) synthesis assay was developed to assess 
the effects of a pulsed radiofrequency (PRF) signal [Muehsam et al., 2012a], 
based upon previous the hypotheses [Muehsam et al., 1994, 1996, 1999, 2009a, 
2009b; Pilla et al., 2006] that EMF effects operate by modulating Ca2+ binding to 
CaM, and thus are observable only when the free cytosolic Ca2+ concentration is 
rate determining. NO synthesis was quantified using the Hb assay [Hevel et al., 
1994]. The effects of PRF on Ca2+/CaM binding were also assessed directly, using 
a Ca2+-selective electrode. No effects of PRF were observed in either of these 
studies. The results of the NO assay do not support the hypothesis that EMF acts 
directly upon Ca2+/CaM binding to modulate the activity of the NOS enzyme. 
Trials using a Ca2+-sensitive electrode do not support the notion that EMF acts 
upon Ca2+/CaM binding under equilibrium conditions. However, in the former 
trials, the observation of a PRF effect on the interaction of Hb with 
tetrahydrobiopterin led to the development of an in vitro cell-free human Hb 
deoxygenation assay [Muehsam et al., 2012b, 2012c, 2012d] that showed a 
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reduction in the rate of Hb deoxygenation for exposures to both PRF and a static 
magnetic field (SMF), occurring from several minutes to hours after fields were 
removed. Structural studies were conducted to assess the effects of EMF on Hb 
using pyranine fluorescence, Gd3+ vibronic sideband luminescence and attenuated 
total reflectance Fourier transform infrared (ATR-FTIR) spectroscopy. Structural 
studies showed no definitive changes in protein structure, suggesting the necessity 
of developing a real-time instrumentation to assess the submolecular causes for 
the EMF effects observed. Also, the effect of SMF on Hb oxygen saturation 
(SO2) was assessed under gas-controlled conditions, with results suggesting that 
the SMF does not directly remove oxygen under equilibrium conditions. 
Theoretical models were developed treating EMF primary transduction and 
effects on ion binding, protein hydration, neuronal spike timing, membrane 
potential, and molecular dynamics of Hb deoxygenation. 
 
The EMF sensitivity and biochemical simplicity of the Hb deoxygenation assay 
developed here suggest a new tool that may help to further establish basic 
biophysical EMF transduction mechanisms. The EMF effects observed are robust 
and were repeated in NY and Bologna using human Hb from different stocks. To 
my knowledge, this is the first report showing that a PRF signal, and 
independently, a SMF could affect similar outcomes in the same in vitro 
biological system, in the same study. Enhanced delivery of oxygen has been 
shown to reduce inflammation [Bitterman, 2007] and enhance tissue repair 
[Tandara et al., 2004] and at least one trial has reported an EMF-induced increase 
in deoxyHb in an in vivo animal model [Milweski, 2006]. Allosteric modification 
of Hb has been suggested as a clinically useful means of enhancing oxygen 
delivery [Papassotiriou et al., 1998], and is in development for in vivo treatment of 
ischemia from stroke, cardiac disease and diabetic ulcers [Najjar et al., 2005]. 
Well-known interactions of NO with hemoprotein transition metals [Ignarro et al., 
1986; Thomas et al., 2003; Bonaventura et al., 2001] and recent results clearly 
demonstrating regulation by endothelial Hb alpha of the action of NO on vascular 
reactivity at the myeloendothelial junction [Straub et al., 2012] and the in vivo 
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modulation of Hb oxygen affinity by NO synthase activity [Zinchuk, 1999] may 
also suggest that the molecular dynamics exhibited by neuroglobin and other 
hemoproteins [Frauenfelder et al., 2009] play an important role in EMF-mediated 
regulation and maintenance of biological growth and repair processes. Although 
much further work is required to ascertain the clinical relevance of the results 
reported here, if an EMF-induced increase in the rate of deoxygenation can be 
demonstrated in vivo, then a resulting enhancement of oxygen delivery may be an 
important non-invasive, non-pharmacologic therapeutic method by which 
clinically relevant EMF-mediated enhancement of growth and repair processes 
can occur.  
 
 
EMF Exposures 
The EMF exposures used for all the experiments described here were chosen for 
their reported therapeutic efficacy. PRF signals and SMFs have been employed in 
a variety of therapeutically relevant settings. For example, variants of the PRF 
signal employed in the this study, and currently in clinical use for the treatment of 
pain and edema, have been shown to: accelerate growth factor production in tissue 
repair [Aaron et al., 2004]; increase neovascularization and enhance skin flap 
survival [Roland et al., 2000; Weber et al., 2004]; modulate anti-CD3 binding at 
lymphocyte receptors [Nindl et al., 1997]; accelerate wound repair [Strauch et al., 
2007]; accelerate Achilles’ tendon repair [Strauch et al., 2006]; reduce 
inflammation and post-operative pain [Heden et al., 2008; Rhode et al., 2010]; and 
enhance chronic wound repair [Kloth et al., 1999]. Reports of therapeutically 
relevant effects of magnetic fields include modulation of calmodulin-dependent 
mysosin phosphorylation [Markov et la., 1997] and cyclic nucleotide 
phosphodiesterase activity [Liboff et al., 2003]; changes in the dielectric 
properties of solutions [Jones et al., 1987]; increases in neurite outgrowth in 
embryonic chick ganglia [McDonald 1993]; changes in morphology of rat tendon 
fibroblasts [Blumenthal et al., 1997]; blockage of action potentials in cultured 
neurons [McLean et al., 1995; Cavapol et al., 1995]; enhancement of cutaneous 
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microcirculation in a rabbit model [Ohkubo et al., 1997; Okano et al., 1999] and 
enhancement of wound healing in rats [Henry et al., 2008; Patiño et al., 1996]. 
SMF exposures have been shown to produce, in in vivo, double-blind studies: 
reduction in discoloration, edema and pain post suction lipectomy [Man et al., 
1999]; reduction in fibromyalgia pain and sleep disorders [Colbert et al., 1999; 
Alfano et al., 2001]; reduction in chronic pelvic pain [Brown et al., 2002]; relief 
from pain, numbness and tingling due to diabetic peripheral neuropathy 
[Weintraub, 1999; Weintraub et al., 2003]; and reduction in post-polio pain 
[Valbona et al., 1997]. Other trials demonstrated no effects on foot [Caselli et al., 
1997; Winemiller et al., 2003], and chronic back pain [Collacott et al., 2000], 
although the latter two trials employed magnets in bipolar configuration, resulting 
in lower amplitude inside the target as compared to unipolar configuration. 
 
The 27.12 MHz PRF signal employed in these studies was transmitted in 4 ms 
bursts, repeating at 5 Hz, 10 µT peak amplitude (Ivivi Health Sciences, USA), and 
is currently approved by the US FDA for clinical use for treatment of pain and 
edema, and by reimbursed Medicare for treatment of chronic wound. The PRF 
signal was delivered with a 20 cm circular single turn antenna (coil). This resulted 
in a mean induced electric field of 3 ± 1 V/m in the sample. PRF field parameters 
were assessed and verified for each experiment using a calibrated field probe 
(model FCC-301-1-MR1, Fischer Custom Communications, Torrance, CA) 
connected to a calibrated 100-MHz oscilloscope (model 2358, Tektronix, 
Beaverton, OR). All components of this PRF transmitter were previously mapped 
by me at 1-2 mm resolution in order to fulfill the requirements of the US FDA for 
approval for clinical use. The static magnetic field employed in these studies 
(SMF, 150 - 186 mT) was delivered using circular permanent ceramic magnets 
3.8 cm in diameter and 1.3 cm thick, intended for therapeutic applications 
(Magnetherapy, West Palm Beach, FL, USA). The SMF amplitude was assessed 
and verified for each experiment using a digital magnetometer (model TM-401, 
Kanatec, Tokyo, Japan). All biological samples were exposed to the ambient 
magnetic field, which was measured using a digital Gauss/Tesla meter (model 
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7010, F.W. Bell, USA) to be 40.5 ± 2 µT, 59 degrees from horizontal (vertical 
component = 34.7 ± 2 µT, horizontal component = 21.0 ± 2µT). Temperature 
variation between exposed and control samples was less than ± 0.1° C [Fisher 
AB15 BioBasic, USA]. 
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2. EFFECT OF A PULSED RADIOFREQUENCY ELECTROMAGNETIC 
FIELD ON ION BINDING SYSTEMS 
 
INTRODUCTION 
In the light of the above reports describing EMF effects on Ca2+/CaM-dependent 
enzyme syntheses, we considered Ca2+/CaM-dependent NO synthesis to be a 
reasonable candidate for another EMF sensitive signaling pathway. The NO 
pathway, which plays a role in a variety of growth and repair processes, responds 
rapidly to departures from intracellular Ca2+ homeostasis and plays a role in a 
variety activities of therapeutic interest. For example, NO signaling plays a role in 
tissue maintenance [Madhusoodanan et al., 2007] and in the production of heat 
shock proteins relevant to the inflammatory, repair, and regenerative phases of 
healing [Kim et al., 1997; Steensberg et al., 2007; Li et al., 2008]. Transient 
changes in cytosolic Ca2+ due to external stimuli such as changes in temperature 
and mechanical forces or injury, activate CaM [Colomer et al., 2007], thus 
activating the constitutive nitric oxide synthase (cNOS) enzymes, i.e., endothelial 
and neuronal NOS, or eNOS and nNOS, respectively. Studies have shown that 
both forms are inactive at basal intracellular levels of Ca2+, however, their activity 
increases with elevated Ca2+, reaching half-maximal activity at about 300 nM 
[Bredt et al., 1990; Schmidt et al., 1991]. The importance of NO signalling in 
therapeutic and repair processes have been the subject of a large body of research 
[Hill et al., 2010]. As a gaseous free radical with a half-life of about 5 s [Ignarro et 
al., 1993], NO diffuses locally through membranes and organelles, acts on 
molecular targets at a distance up to 200 µm from the location of synthesis 
[Malinski et al., 1993; Wood et al., 1994; Tsoukias, 2008], and has been shown to 
exhibit a high affinity for transition metal centers, in particular ferrous heme and 
for hemoproteins such as soluble guanylyl cyclase (sGC) and hemoglobin [Ignarro 
et al., 1986; Thomas et al., 2003]. NO has also been recently demonstrated to be 
regulated by Hb-alpha in the myeloendothelial junction, suggesting a role for 
globular proteins in the availability of NO [Straub et al, 2012].  
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Small changes in the basal concentrations of NO from cNOS can activate the 
hemoprotein sGC, which catalyzes the synthesis of cyclic guanosine 
monophosphate (cGMP) [Cho et al., 1992]. This CaM-activated NO/cGC/cGMP 
signaling pathway is a rapid response cascade, mediated by NO binding to the 
ferrous heme [Ignarro et al., 1986] which modulates peripheral and cardiac blood 
flow in response to normal physiologic demands, as well as to inflammation 
[Bredt, 2003]. This same pathway also modulates the release growth factors such 
as basic fibroblast growth factor (FGF-2) and vascular endothelial growth factor 
(VEGF) [Madhusoodanan et al., 2007; Werner et al., 2003] involved in tissue 
repair and maintenance. Evidence for NO control of Ca2+-activated K+ channels 
also suggests that attempts to observe of EMF effects in patch-clamped ion 
channels [Höjevik et al., 1995; Tonini et al., 2001; Obo et al., 2002] might be 
informed by accounting for NO signaling and Ca2+/CaM binding [Bolotina et al., 
1994; Lu et al, 1998]. NO signalling also acts in a variety of pathways in the 
nervous system, and a brief glance at the literature suggests: control of CREB-
mediated gene expression in neurons [Riccio, et al., 2006], in conjuction with 
histone deacetylases [Watson et al., 2009], epigenetic changes associated with cell 
cycle arrest and differentiation [Nott et al., 2009], human chondrocyte 
proliferation [Fitzsimmons et al., 2008], regulation of transcription factors 
[Contestabile 2008], survivability of neurons [Ciani et al., 2002], and recycling of 
BDNF by hippocampal neurons [Aicardi et al., 2004; Santi et al., 2008].  
 
 
Nonthermal EMF Bioeffects Relevant to the Ca2+/CaM/NO Pathway 
The growing interest in pulsed EMF (PEMF) therapeutics has resulted large body 
of evidence demonstrating effects of nonthermal fields on a variety of biological 
systems. For example, a variety of bioeffects have been reported for nonthermal 
PRF fields, for time-averaged heating is negligible [Foley-Nolan et al., 1990; 
1992; Kloth et al., 1999; Mayrovitz et al., 1992; 1995; Mayrovitz et al., 2002; 
Salzberg et al., 1995; Pennington et al., 1993; Pilla et al., 1996]. Of particular 
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interest due to their relevance to CaM/NO signaling, are studies reporting: 
nonthermal PEMF enhancement of nNOS expression and phospholipase C-
gamma1 in regenerating murine neuronal cells [Kim et al., 2002]; NO-mediated 
effects of pulsed electromagnetic field stimulation on osteoblast proliferation and 
differentiation [Diniz et al., 2002]; increased rat osteoblast differentiation and 
maturation via activation of NO-cGMP-PKG pathway [Cheng et al., 2011]; 
increase in NO transient expression in MN9D cells [Pilla, 2012]; modulation of 
release of both growth factors and cytokines [Seegers et al., 2001; Brighton et al., 
2001; Aaron et al., 2004; Li et al., 2007; Callaghan et al., 2008; Fitzsimmons et 
al., 2008; Rohde et al., 2009]; down-regulation of the inducible isoform of NOS, 
iNOS, in monocytes [Reale et al., 2006]; reduction in pro-inflammatory cytokines 
in human keratinocytes [Vianale et al., 2008]; modulation of the sequential 
expression of iNOS, eNOS and cyclooxygenase-2 (COX-2) in human 
keratinocytes, although in this study this is likely to be magnetic field effect 
[Patruno et al., 2010]; protective effect on dopaminergic neurons from several 
types of toxicity [Casper et al., 2006]; increase in cGMP in endothelial cells 
[Tepper et al., 2004; Callaghan et al., 2008]; increase in cGMP in MN9D 
dopaminergic neurons [Casper et al., 2008]; increase in articular chondrocyte 
proliferation [Fitzsimmons et al., 2008]. While the above bioeffects suggest a link 
to EMF modulation of NO signaling pathways, these effects also cannot be 
attributed to EMF heating of the target tissues, thus suggesting that nonthermal 
mechanisms exist. 
 
The experiments conducted here considered in vitro cell-free Ca2+-CaM-
dependent NO synthesis. Our working hypothesis for EMF effects on NO 
synthesis was that EMF acts upon Ca2+/CaM binding, thus resulting in a 
modulation of NO synthesis according to Figure 1. Schematically, transient 
changes in free cytosolic Ca2+ are rapidly detected by CaM [Blumenthal et al., 
1982], resulting in concomitant changes in the concentration of activated CaM*, 
which then binds to and activates the constitutive enzyme cNOS, i.e. neuronal 
nNOS or endothelial eNOS. The activated enzyme cNOS* then, in conjunction 
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with the necessary redox cofactors nicotinamide adenine dinucleotide phosphate 
(NADPH), tetrahydrobiopterin (H4B), flavin mononucleotide (FMN), flavin 
adenine dinucleotide (FAD), converts L-arginine to citrulline, in the process 
releasing one mole of both NO and citrulline for each mole of L-arginine. The 
vertical arrow represents the recycling of the enzyme and subsequent release of 
CaM from cNOS* which is required for the release of Ca2+ from CaM [Cox, 
1988; Daff, 2003]. 
 
 
Figure 1. Schematic representation of the NO synthesis pathway. EMF was 
assumed to act upon Ca2+/CaM binding, thus resulting in a modulation of NO 
synthesis.  
 
 
 
MATERIALS AND METHODS  
In order to assess the possibility that this enzymatic synthesis could be a sensitive 
detector to changes in CaM activation due to EMFs, we chose to perform EMF 
exposures under conditions for which Ca2+/CaM binding was rate-limiting. Thus, 
if the effect of the EMF was to enhance the binding of Ca2+ to CaM, and thus 
concentration of CaM*, this would result in an increased rate of NO synthesis. 
This required the control of free Ca2+ using EGTA, and the use of purified 
preparations of CaM and the NOS enzyme, to minimize interference due to 
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residual Ca2+ and/or CaM. After initial unsuccessful attempts to measure NO 
synthesis using the Griess assay (due to NADPH interference) [Griess, 1879; 
Weissman et al., 2001] and a NO-selective electrode (due to problems with 
stirring, temperature control, and the rapid rate of NO conversion to nitrite) [See 
Appendix to this Chapter], we chose to quantify NO synthesis using the 
hemoglobin assay [Hevel et al., 1994; Murphy et al., 1994].  This method takes 
advantage of the rapid scavenging of NO (k ≈ 107 M-1⋅s-1)[Doyle et al., 1981; Eich 
et al., 1996; Herold et al. 2001] by oxygenated Hb (oxyHb), and the resulting 
conversion of oxyHb to metHb which may then be quantified using visible light 
spectroscopy to yield the molar concentration of NO synthesis [Hevel et al., 
1994]. 
 
Reaction mixtures consisted of 50 mM HEPES buffer, pH 7.4; 50 µM L-arginine; 
170 µM DTT; 0.2-4 µM CaM; 0–2 mM CaCl2; 0-2 mM EGTA, pH 8.0; 50 µM 
NADPH; 10 µM H4B; nNOS or eNOS 0.25-1 U/mL. All reagents except CaM 
and some cNOS stocks were obtained from Sigma, USA. Purified Ca2+- and CaM-
free nNOS and eNOS (Sigma, USA; Cayman, USA) were used. Calibration 
experiments showed that additional FAD and FMN was not required for synthesis  
and conversation with Cayman indicated that these were likely residually bound 
to the NOS enzyme. Free calcium concentrations were controlled in the 0.1–1.0 
µM range via EGTA [Schoenmakers et al., 1992] and NO synthesis was 
quantified at 401, 411 and 421 nm [Hevel et al., 1994] using a Molecular Devices 
190 spectrophotometer. Over the course of at least 48 independent experiments, 
reactions were initiated with nNOS or eNOS 0.25-1 U/mL + 10 µM H4B, or 50 
µM NADPH + 10 µM H4B. Trials were also conducted wherein the reaction was 
initiated using Ca2+ + H4B or CaM + H4B, all other reagents being in the reaction 
stock mixture. Enzymatic synthesis was halted through the addition of 5 mM 
EGTA in 50 mM Hepes buffer. For all calibration experiments, negative controls 
were performed by adding the appropriate volume of Hepes + H4B rather than the 
above initiating reagents. Purified Ca2+-free CaM used here was shown to yield 
negligible NO synthesis, confirming the Ca2+-dependence of CaM activity. 
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Similar results were produced for the purified Ca2+/CaM-free NOS employed for 
these experiments. In the absence of enzymatic NO donation, no effects of PRF 
were observed on the location of the Hb peak in the 406-415 nm range, 
corresponding to met-Hb conversion due to NO. In order to obviate errors due to 
the interactions of H4B with HB [Hevel et al., 1994], H4B was left out of the 
stock solutions until the final step of reaction initiation. In order to insure that 
experiments were performed in the linear region (R2 = .998) of NO synthesis, for 
which Ca2+-CaM binding is rate-limiting [Wrighton et al., 1993.], time series of 
the NO synthesis were obtained for all experiments using PRF exposure, and also 
for all new combinations of reagents, and when new stocks of critical ingredients 
such as cNOS, CaM, Hb, etc., were obtained. Trials were performed either in 
batches of 3-10 tubes for each EMF exposure condition, or an alternating design 
with PRF coil active or inactive for successive tubes, reacted independently, with 
n = 10 tubes for each EMF exposure condition. Stock solutions were aliquoted 
into individual 1.5 mL Eppendorf tubes which were kept on ice until immediately 
prior to reaction. In order to obviate artifacts due to H4B interactions with Hb 
[Hevel et al., 1994], visible light spectra were read for each tube immediately after 
EGTA quenching. Calibration experiments confirmed a reduction in Hb optical 
density with increasing H4B concentration. Titrations were performed for each 
experimental condition to record the location relative to saturation on Ca2+ 
activation curve. A wide range of ratios of enzyme to substrate was tested, and 
EGTA titration was performed for each in order to establish specific Ca2+ 
dependence. EGTA titrations were also performed for each new batch or reagents 
or upon freeze-thawing the NOS enzyme. Hb concentrations were optimized in 
the low µM-range for each experiment to yield sufficient sensitivity, dependent 
upon the current enzyme activity and number of units of NOS used in specific 
experiments. Times series were performed for each exposure condition and final 
reaction times between 1-10 minutes were chosen in order to insure that all 
experiments were conducted within the linear range of synthesis. NO synthesis 
was carried out at 37° C and quantified spectrophotometrically by measuring 
visible light absorbance at 401, 411 and 421 nm. The PRF signal was as described 
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in Chapter 1, and generated by a 20 cm coil surrounding the plastic water bath 
housing containing samples, as shown in figure 2. In order to maximize the 
electric field induced in the tubes, the coil was placed parallel to the long axis of 
the tubes. For each experiment, five 1.5 mL microfuge tubes containing the NOS 
preparation were exposed to PRF + ambient of ambient alone (PRF coil inactive) 
for the 1-10 min duration of enzymatic synthesis. 
 
 
 
Figure 2. PRF exposure system for NO synthesis. Samples undergo NO synthesis 
in water bath at 37° C during exposure to 10 µT 27.12 MHz PRF field.  
 
Further experiments were carried out using a Ca2+-selective electrode (Fisher 
9720BNWP) to measure the equilibrium binding of Ca2+/CaM [Iida et al., 1986; 
Iida 1988; McGuigan et al., 2006] under PRF+ambient and ambient-only EMF 
exposure conditions. The electrode was rated by the manufacturer to provide a 
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500 nM sensitivity to Ca2+ concentration. Experiments were carried in 50 mM 
Hepes buffer, pH 7.2, at 22° C, using purified Ca2+-free CaM (Ocean Biologics, 
USA). In one set of experiments, total CaCl2 concentration was raised in 10 µM 
steps in a solution of 12.5 µM Ca2+-free CaM in 10 mL volume. A second series 
of trials, consisted of adding 62.5 µM CaM in 200 µL aliquots to 10 mL of 30 µM 
CaCl2 solution, allowing for direct observation in electrode potential due to uptake 
of Ca2+ by CaM. Electrode potentials were recorded after a time period sufficient 
to produce a stable electrode potential, usually approximately 40-60 seconds, 
allowing a direct observation of the change in Ca2+ concentration due to Ca2+ 
uptake by CaM. Both series of trials were repeated 5 times at 22° C for 
PRF+ambient and ambient-only exposure conditions. No changes in electrode 
potential were observed when buffer solution was substituted for Ca2+ or CaM. 
 
 
RESULTS 
The NO synthesis assay developed here was able to detect in the enzymatic 
activity, small nm-range changes in free Ca2+ concentrations. Through the use of 
purified Ca2+-free CaM and purified Ca2+-CaM-free cNOS, EGTA titration 
allowed repeatable control of the enzymatic synthesis through adjustment of free 
Ca2+ concentration. Figure 3, left hand plot, shows the Hb optical density (OD) 
spectra data from the visible light spectrophotometer for a typical EGTA titration 
in our assay, using a 10 min reaction time, ¼ U nNOS and 1 mM total Ca2+. The 
production of NO and resulting conversion of oxyHb to metHb is evidenced by 
the passage with decreasing EGTA (i.e. more free Ca2+ and thus greater NO 
synthesis) of the characteristic Hb peak to 415 nm to the left, finally settling at 
approximately 406 nm for full oxy-met conversion [Hevel et al., 1994]. The 
isosbestic point at approximately 411 nm yields an indication of the pipetting 
accuracy for a given experiment. Figure 3, right hand plot, shows NO via the 
method of Hevel et al., 1994, using the OD at 401, 411 and 421 nm to compute 
the molar concentration of NO from the linear relation given by Hevel et al., 
1994: NO(µM) = 103(∆401-∆411)/pε, where p = path length (cm) and ε = 38  
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mM-1cm-1. Error bars are given by SEM for triplicate samples taken from each 
microfuge tube. Thus, we developed an assay which allowed, by varying free 
Ca2+ using EGTA, for the control of NO synthesis from zero synthesis (as given 
by the resolution of the Hb assay) into the µM range. Similarly, greater accuracy 
was obtained by keeping the EGTA concentration constant and adjusting the total 
Ca2+ concentration, as shown here in figure 4, left hand plot, using a 4 min 
incubation, ½ U eNOS (Cayman), 400 nM CaM, and 1 mM EGTA. Again, 
synthesis may be measured from the lower limit of the assay to the µM range, and 
exhibits saturation in this experiment at approximately 1 mM total added Ca2+. 
Interestingly, as the total Ca2+ concentration increased above saturation, a small 
but marked inhibition of NO synthesis was observed, in accord with previous 
observations suggesting the existence of additional weak affinity sites on 
Calmodulin [Bredt et al., 1990; Weissman et al., 2002]. Making use of EGTA 
titration data [Schoenmakers et al., 1992], the dependence of NO synthesis upon 
free Ca2+ concentration may be estimated, as shown in Figure 4, right hand plot. 
Also, the time series of the NO synthesis was obtained for all experiments with 
PRF, new combinations of reagents, and when new stocks of critical ingredients 
such as cNOS, CaM, Hb, etc., were obtained. A typical time series is shown in 
Figure 5, using the above combination of reagents with ¼ U nNOS. Time series 
data was essential in order to insure that experiments were performed in the linear 
region (R2 = .998) of NO synthesis, for which Ca2+-CaM binding is rate-limiting. 
The results show that the assay developed here exhibits a low-nm-range 
sensitivity to changes in the concentration of free Ca2+, thus suggesting the 
application of this cell-free system to our hypothesis that EMF may modulate NO 
synthesis by affecting Ca2+/CaM binding in the 300 nm range of half-maximal 
basal concentrations observed to modulate in vivo NO synthesis [Bredt et al., 
1990; Schmidt et al., 1991]. 
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Figure 3. Left: Change in optical density (OD) of spectra of Hb in NOS synthesis 
assay corresponding to oxy-met Hb conversion due to NO uptake. Data from 
visible light spectrophotometer for a typical titration of EGTA from 0 – 3.5 mM. 
Peak at 415 nm characteristic of oxyHb moves to the left with decreasing EGTA 
(i.e. more free Ca2+, and thus greater NO synthesis). Right: Concentration of NO 
in reaction mixture, from data on left, using the method of Hevel et al., 1994. 
Results show that NO synthesis is controlled from the lower limit of resolution of 
the assay to the µM range.  
 
 
Figure 4. Left: NO synthesis as a function of total added Ca2+ concentration, 
keeping EGTA constant = 1 mM. Rate of synthesis reaches saturation at 
approximately 1 mM total Ca2+ concentration, defining range over which NO is 
dependent upon added Ca2+. Right: Free Ca2+ concentration for a similar 
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experiment, using EGTA chelation data banks. The results show that the assay 
developed here exhibits a physiologically relevant low-nm sensitivity to free Ca2+ 
concentration, thus suggesting application to our hypothesis of Ca2+/CaM binding 
as the EMF-sensitive step in NO synthesis. 
 
 
Figure 5. Typical time series for NO synthesis, using ¼ U nNOS, 400 nM CaM, 
and 1 mM EGTA. Time series were performed for all experiments in order to 
ensure that reaction was in the linear portion of synthesis for which Ca2+-CaM 
binding is rate-limiting. 
 
For preliminary trials, similar titrations were performed for several combination 
of ratios of enzyme/substrate, and PRF exposure of NO synthesis was performed 
at 2 or more points in the range of free Ca2+ concentrations for which Ca2+-CaM 
binding was rate-limiting. For these trials, PRF and ambient only exposures were 
performed in batches of 5 tubes for each condition, in an experimental design that 
alternated the order of PRF and ambient (control) exposures. After these initial 
trials revealed a promising combination of reagents which exhibited a non 
statistically significant trend towards an increase in NO synthesis with PRF 
exposure, it was decided to perform a lengthy series of trials using one 
combination of reagents, in hopes of establishing significance. Using a 5 min 
incubation time, ½ U/mL nNOS, 1 mM CaM, 1 mM Total Ca2+, 2 mM EGTA and 
all other reagents as described in the Methods section above. For these conditions, 
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free Ca2+ may be estimated at approximately 281 nM [Schoenmakers et al., 1992], 
corresponding to approximately 28% of saturation NO activation in our assay. In 
other words, we chose a location on the Ca2+ binding curve, well below saturation, 
yet high enough to allow reliable detection of NO via Hb oxy-met conversion. For 
these conditions, we found a statistically significant increase in NO synthesis, 
such that NO synthesis for PRF/null = 1.22, P = 0.02, n = 25. However, these 
results were obtained by an accumulation of data over 7 experiments, each using 
3-4 tubes per exposure condition. The results required n = 25 tubes in order to 
achieve statistical significance, and individual experiments within this data set 
yielded both increases and decreases in NO, suggesting that the effect observed 
was due to the accumulation of variability within the assay itself. Thus, these data 
were not considered to be a reliable assessment of the EMF sensitivity of the NO 
assay. In hopes of producing a more effective assay for EMF sensitivity, a final 
group of trials employed an alternating exposure design, wherein each tube was 
individually reacted and assessed spectrophotometrically for NO synthesis, and 
PRF and control exposures were alternated for each tube. Several extensive 
conversations were conducted with Dr. Marko Markov, the author of several 
papers reporting EMF effects on Ca2+/CaM-dependent myosin phosphorylation 
[Markov et al., 1992, 1993, 1994, 1997], in hopes of obtaining better knowledge 
of the conditions for which Ca2+/CaM binding exhibits EMF sensitivity. The 
Ca2+/CaM/EGTA concentrations employed by Markov were used for several of 
these trials, and several different means of initiating the reaction were also 
employed, such as initiation using CaCl2, nNOS, CaM, and NADPH. None of 
these trials yielded significant changes in NO synthesis for PRF as compared to 
ambient exposures, with a metanalysis over the last 10 trials showing NO 
synthesis for PRF/null = 0.99, P =0.72, n = 100 tubes, 10 individual experiments, 
as summarized in Figure 6. One trial, ‘PRF 3,’ appeared promising, however the 
results were not repeatable in the successive trial. If this experiment is removed as 
an outlier from the metanalysis shown below, then the final result for NO 
synthesis for PRF/null = 1.00 (0.998669), P = 0.78, n = 90 tubes, 9 experiments. 
However, subsequent analysis of the Hb spectra showed that some trials exhibited 
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showed a statistically significant increase in the optical density of the 411 nm 
isosbestic point 2.8% higher OD than untreated, (P = 0.04, n = 3), suggesting the 
possibility of a PRF effect on Hb itself. 
 
  
expt 
EGTA 
(mM) Ca total (uM) 
Ca free 
(M) 
CaM 
(nM) 
NO 
+PMF/-
PMF T test P = 
PRF 1 1 250 3.93e-8 1500 1.03 0.31 
PRF 2 1 900 1.05e-6 200 1.02 0.80 
PRF 3 1 900 1.05e-6 200 0.86 0.15 
PRF 4 1 900 1.05e-6 200 0.97 0.38 
PRF 5 1 900 1.05e-6 800 0.97 0.88 
PRF 6 1 900 1.05e-6 800 1.00 0.99 
PRF 7 1 900 1.05e-6 800 0.99 0.87 
PRF 8 1 400 7.87e-8 200 1.00 0.97 
PRF 9 2 500 3.93e-8 5000 1.00 0.97 
PRF 10 2 500 3.93e-8 5000 1.01 0.89 
    mean 0.99 0.72 
 
Figure 6. Summary of the final 10 trials, for which the NO synthesis assay 
employed an alternating design of PRF and control exposures with each 
microfuge tube reacted and assessed individually. Results show no effects of PRF 
on NO synthesis for any of the individual experiments. The overall average ratio 
of NO synthesis for PRF/null = 0.99, P =0.72. Each experiment consisted of n = 
10 tubes for each exposure condition. 
 
 
Trials performed allowed direct observation of the uptake of Ca2+ by CaM. The 
addition of successive 10 µM aliquots of CaCl2 to 12.5 µM Ca2+-free CaM in a 10 
mL reaction volume produced no significant difference in equilibrium electrode 
potential for PRF vs ambient exposures, as shown in Figure 7, left hand plot. No 
significant differences were found for trials in PRF field, 0.38 < P < 0.86 for all 
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points in curve, n = 5. Also, addition of calmodulin to CaCl2 solution offered a 
unique opportunity to directly observe the decrease in free Ca2+ concentration 
with the addition of 62.5 µM CaM in 200 µL aliquots. Again, no significant 
differences were found for trials in PRF field, 0.23 < P < 0.91 for all points in 
curve, n = 5. Thus, Ca2+/CaM binding, measured using the Ca2+-selective 
electrode employed here, yielded no significant changes in Ca2+/CaM equilibrium 
binding across the range of concentrations measured here. The size of the SEM 
error bars shown here provides an indication of the electrode stability and the 
repeatability of these results. 
 
Figure 7. Left: addition of CaCl2 to calmodulin solution: CaCl2 concentration 
was raised in 10 µM steps in a solution of 12.5 µM Ca2+-free CaM in 10 mL 
volume. No significant differences were found for trials in PRF field, 0.38 < P < 
0.86 for all points in curve. Right: addition of calmodulin to CaCl2 solution: 62.5 
µM CaM was added in 200 µL aliquots to 10 mL of 30 µM CaCl2 solution, which 
allowed for direct observation of the uptake of Ca2+ for each aliquot of CaM. No 
significant differences were found for trials in PRF field, 0.23 < P < 0.91. 
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DISCUSSION AND CONCLUSIONS 
The enzymatic synthesis of NO performed here was able to detect changes in free 
Ca2+ concentrations on the order of 100 nM, corresponding to the basal changes 
known to activate NO synthesis in vivo [Bredt et al., 1990; Schmidt et al., 1991]. 
Over the course of at least 48 independent experiments with PRF exposures, no 
significant differences in NO synthesis were found for PRF vs. null exposures. 
Although a trend was observed for one set of trials, a large number (25) of trials 
were required to yield statistical significance, and we thus attributed this result to 
variability in the assay itself, rather than a PRF effect. Further trials, carefully 
controlling conditions by reacting and assaying each tube individually in an 
alternating design for EMF exposures yielded no PRF significant effects, with the 
ratio of NO synthesis for PRF/null being very close to unity.  
 
Over the course of at least 48 independent experiments with PRF exposure for 
which Ca2+-CaM binding was rate-limiting, no significant differences in NO 
synthesis were found. Thus, the results reported here do not support that 
hypothesis that PRF acts upon Ca2+/CaM binding to yield an effect observable 
using this in vitro cell-free assay, i.e. within the approximately 100 nM resolution 
of the assay. Although a body of literature exists concerning NO/NOS/Hb 
interactions, including the inhibition of NOS by Hb and even NO itself 
[Griscavage et al., 1994; Kopincová et al., 2011], which could conceivably mask 
or counterbalance a PRF effect on Ca2+/CaM binding, the assay performed here 
exhibits a clear, quantifiable dependence upon Ca2+/CaM binding, so that PRF 
induced changes in CaM activation should be observable if greater than the 
resolution of the assay. It is highly unlikely that a putative PRF effect directly on 
Hb or NO/NOS/Hb interactions acted in an exactly equal and opposite direction as 
the hypothesized effect on Ca2+/CaM binding, thus masking precisely the action 
of the PRF on Ca2+/CaM. However, changes in Ca2+/CaM binding below the 
resolving power of this assay could have occurred, and one means assaying NO 
with a potential for pM-range resolution is the citrulline assay which measures 
directly the radioactively labelled product of the enzyme reaction [Hevel et al., 
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1994; Bredt et al., 1989; Ward et al., 1999]. Indeed, such a sensitivity may be 
necessary in order for the results to be relevant to the function of NO signalling in 
guanylyl cyclase receptors [Batchelor et al., 2010]. Trials reported here employing 
a Ca2+-selective electrode further lend support to the notion that the equilibrium 
concentration of activated CaM is not altered by the PRF signal utilized in this 
study, within the 500 nM electrode resolution. A real-time assay using a Ca2+-
selective electrode might enable a study of the binding kinetics Ca2+ with CaM, 
but was obviated here by the high cost of Ca2+-free CaM. 
 
These results are in contrast to reports of a PRF effect on Ca2+/CaM dependent 
myosin phosphorylation [Markov et al., 1994], wherein a nearly twofold increase 
in phosphorylation was reported for a PRF signal with waveform parameters (0.05 
G, 2 ms, 1 Hz) similar to those employed here (5 µT, 2 ms, 1 Hz). For these 
experiments, Ca2+ and CaM were placed together in the reaction mixture with 
myosin light chain kinase before initiating the reaction with ATP and were thus at 
equilibrium. Assuming Ca2+/CaM as the EMF-sensitive target, such an effect 
would have required a concomitant increase (i.e. a doubling) in activated CaM, 
due to PRF. As several of the trials on NO synthesis reported here employed the 
same Ca2+/CaM combination as the experiments of Markov et al., such a doubling 
would have lain clearly within the resolution of our assay. Trials reported here 
employing a Ca2+-selective electrode further lend support to the notion that the 
equilibrium concentration of activated CaM is not altered by the PRF signal 
utilized in this study, within the 500 nM electrode resolution. One possible 
interpretation is that the data presented here suggest that earlier reports of EMF 
effects may have acted upon transient non-equilibrium concentrations during 
synthesis and re-cycling of the enzyme, or were due to effects on 
enzyme/substrate/cofactor interactions. This may shed light on unsuccessful 
attempts at replication of EMF effects in Ca2+/CaM dependent systems [Bruckner-
Lea et al., 1992; Hendee et al., 1996; Coulton et al., 2000;]. Several trials with low 
values of free Ca2+ showed a statistically significant 2.8% (P < 0.04, n = 3) 
increase in absorbance at the Hb isosbestic point at 411nm, suggesting the 
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possibility of a PRF effect on Hb itself. Calibration experiments showed a 
reduction in Hb optical density with increasing H4B concentration, and this effect 
was partially mitigated by the PRF signal, perhaps suggesting an EMF effect on 
the action of H4B on Hb. However, because of the episodic nature of this result 
and the absence of a clinically relevant literature detailing direct Hb-H4B 
interactions, we chose not to study the effect of EMFs on these interactions. 
 
 
 
APPENDIX 
QUANTIFYING NO SYNTHESIS USING AN NO-SELECTIVE 
ELECTRODE 
 
“Any newcomer to the NO field is confronted with a bewildering nomenclature 
that uses very similar sounding names to describe very distinct molecules, e.g. 
nitrous oxide (laughing gas) and nitric oxide (sometimes called crying gas by 
those working on it!).”   [Hill et al., 2010] 
 
The difficulties encountered in the accurate measurement of NO are familiar to 
many researchers, and stem from NO being a highly gregarious free radical with a 
high reactivity for transition metals and other radicals [Tsoukias et al., 2003], and 
also the natural oxidation of NO to nitrite [Ignarro et al., 1993]. This oxidation to 
nitrite, which occurs with a half-life of approximately 5 seconds, occurs in vitro, 
and is one source of difficulty in use of NO-selective electrodes to accurately 
quantify NO synthesis [Boo et al, 2007]. Our trials with an NO-selective electrode 
(Model ISO-NOP3020, World Precision Instruments, Sarasota, FL, USA) 
confirmed NO’s dubious properties as a ‘crying gas,’ as we found electrode 
readings to be unreliable for quantifying enzymatic synthesis, and chose to 
abandoned plans to assay NO synthesis with this method. A brief analysis of the 
dynamics of NO synthesis and decay (in the absence of a scavenging agent such 
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as Hb) helps to clarify why detection of NO synthesis using an electrode is 
difficult. 
 
Given a constant linear enzymatic synthesis of NO, as observed here and used by 
manufacturers to define the activity of cNOS enzymes, the rate of change of the 
NO concentration is given by 
 
dN(t)
dt
=α −βN(t)      (1) 
 
where α = 1 nmol/min [Cayman Chemical Item Number 60880, Cayman, USA], 
and the decay constant β for a half-life of 5 second is ln(2)/5. 
 
Eqn. (1) is of the general form 
 
dN(t)
dt
+βN(t) =α      (2) 
 
which admits a solution of the form 
 
N(t) = α e
βt dt∫
β dt∫ ,     (3) 
so that N(t) is given by 
 
N(t) =
α eβt dt
0
t∫
β dt
0
t∫
=
α
β e
βt
−αt
eβt





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0
t
=
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β e
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−αt
eβt
−
α
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Thus, for the conditions we employed, using 1 U NOS in a 5 mL reaction volume, 
with stirring provided by air bubbling through the mixture, the time course of the 
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NO concentration is expected to be as shown in Figure A1. After approximately 7 
seconds, we reach a maximal concentration of of about 44 nM, which is within the 
resolution of the electrode [from World Precision Instruments specsheet]. 
However, after 20-30 seconds, N(t) is in the 10-20 nM range, which is 
approaching the noise level we observed in our electrode. Thus, the window of 
detectability for in vitro synthesis is very short, on the order of 10-15 seconds, and 
accurate measurements cannot be made by hand/eye most likely due to stirring 
artifacts present immediately after initiating the reaction. Figure A2 shows the 
time course of NO concentration for 5, 25 and 50 U nNOS in a 5 mL reaction 
volume. Due to the linear dependence of equation (3) on α, the maximal 
concentration increases linearly with the amount of enzyme used. However, for all 
amounts of the NOS enzyme shown here, the maximal concentration is always 
reached after approximately 7 seconds, and decays rapidly thereafter. The 20 nM 
upper limit of detectability of our electrode is indicated by the horizontal dotted 
line, which shows that even using 5-10 times as much NOS results in only 
approximately a doubling of the time for which the NO concentration lies above 
the electrode resolution. However, in the absence of an automated method for data 
acquisition, considering the high cost of the NOS enzyme (approximately 100 
USD for 5 U at the time of these experiments), we found the electrode inaccurate 
for the quantitative detection on NO. 
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Figure A1. Time course of NO concentration in vitro, accounting for rate of 
enzymatic synthesis and decay to nitrite using 5 U nNOS in a 5 mL reaction 
volume. Maximal concentration of approximately 44 nM is reach after 
approximately 7 seconds. The limit of detectability with our electrode was in the 
10-20 nM range, indicating that after 20-30 seconds the electrode signal is 
embedded in noise. 
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Figure A2. Time course of NO concentration in vitro, accounting for rate of 
enzymatic synthesis and decay to nitrite using 5, 25 and 50 U nNOS in a 5 mL 
reaction volume. Note that for all the amounts of the NOS enzyme shown here, 
the maximal concentration is always reached after approximately 7 seconds. The 
horizontal dotted line shows the 20 nM upper limit of detectability of our 
electrode, thus indicating that even using 5-10 times as much NOS results in only 
approximately a doubling of the time for which the NO concentration lies above 
the electrode resolution. 
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3. EFFECTS OF NONTHERMAL EMF ON HUMAN HEMOGLOBIN 
 
 
a. NONTHERMAL RADIO FREQUENCY AND STATIC MAGNETIC 
FIELDS INCREASE RATE OF HEMOGLOBIN DEOXYGENATION IN A 
CELL-FREE PREPARATION 
 
INTRODUCTION 
The development of the Hb assay presented here stemmed from the observation 
reported above that the NO synthesis assay we developed exhibited in some 
experiments a small, statistically significant 2.8% (P < 0.04, n= 3) increase in 
optical density at the Hb isosbestic point at 411nm. This result suggested the 
possibility of a PRF effect on directly on Hb and inspired confidence in the 
possibility of developing an in vitro assay based upon Hb as a detector of EMFs. 
A survey of recent literature lent further support to the possibility, with report of a 
variety of EMF effects on human Hb in solution and erythrocyte suspensions, 
including decreases in viscosity [Tao et al., 2011.] and changes in impedance 
[Sosa et al., 2005], dielectric properties [Shalaby et al., 2006], dia- and para-
magnetic properties [Sakhnini et al., 2001], optical absorption [Iwasaka et al., 
2001] and in vivo deoxygenation [Milweski et al., 2006]. In addition, 
radiofrequency mobile telephone signals have been shown to decrease Hb oxygen 
affinity in vitro [Mousavy et al., 2009] and changes in infrared absorption have 
been reported for low-frequency EMF [Magazù et al., 2010]. Also, enhanced 
oxygen delivery by Hb is under investigation as a therapeutic strategy for the 
treatment of pathologies such as ischemia from stroke, cardiac disease and 
diabetic ulcers [Najjar et al., 2005]. Thus, the present study was aimed at 
characterizing the effect of a pulse-modulated radiofrequency (PRF) signal 
currently in clinical use for treatment of pain, edema and chronic wounds [Pilla, 
2006; Pilla et al., 2011], and, applied independently, a static magnetic field 
(SMF), from permanent ceramic magnets intended for therapeutic applications 
and reported to reduce pain [Pilla et al., 2006], on the rate of oxygen release from 
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human hemoglobin (Hb) in an in vitro cell-free assay. These non-thermal EMF 
modalities were chosen for this study due to their demonstrated efficacy in a 
variety of therapeutically relevant settings [Pilla et al., 2006]. The reducing agent 
dithiothreitol (DTT) was chosen for the ability to easily control the time course of 
Hb deoxygenation via the ratio of DTT/Hb [Herzfeld et al., 1990]. This study will 
show that exposure to both PRF and SMF, applied independently, yields similarly 
significant increases in the rate of oxyHb → deoxyHb conversion in the presence 
of the reducing agent DTT, observable several minutes to several hours after EMF 
exposure had ended. 
 
 
MATERIALS AND METHODS 
Hemoglobin Preparation 
Fresh human blood was obtained with written donor consent from, and approved 
for research by the Blood Bank at S.Orsola-Malpighi Hospital, Bologna according 
to the rules established by Legislative Decree 03-03-2005, article 9, paragraph 3, 
published in G.U. n. 85, 13.04.2005. Blood samples were also obtained from one 
author (DM) in accord with New York State Consolidated Law, Public Health 
Article 24-A, Section  2442, without written approval of the Institutional Review 
Board of the Albert Einstein College of Medicine. Blood was drawn in EDTA 
anticoagulant tubes, centrifuged at 1000 x g for 10 min and plasma removed. The 
packed erythrocyte suspension was then washed in normal saline and centrifuged 
at 1000 x g for 10 min, 3 times. Erythrocytes were then hemolyzed using distilled 
water, the resulting solution centrifuged at 1000 x g for 10 min, and the Hb-
containing supernatant recovered using a Pasteur pipette. Red cell ghosts were 
sedimented by additional centrifugation, and the resulting solution containing 2-
2.5 mM oxyHb (measured by visible light spectroscopy [Benesch et al., 1973]), 
was stored in 1.5 mL aliquots at -80° C until used for each experiment. Ten mL 
reaction mixtures were prepared using 100-120 µM oxyHb in 50 mM Hepes 
buffer (pH 7.2, Sigma-Aldrich, USA), and oxyHb → deoxyHb conversion 
initiated with 10-30 mM DTT at 22 ± 0.1° C. Trials were also performed with 100 
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mM MgCl2 to the deoxygenation solution [Guo et al., 2009]. Due to the moderate 
volatility of DTT, fresh stock solutions were made immediately prior to each 
experiment. pH was checked with a digital pH meter (Fisher AB15 BioBasic, 
USA) and maintained at 7.2 for all hemoglobin samples used in this experiment. 
Immediately upon addition of DTT, the 10 mL reaction mixture volume was 
divided into 1 mL aliquots in sealed 1.5 mL microfuge tubes. No attempt was 
made to alter the gaseous environment within the tubes.  
 
EMF Exposure 
All hemoglobin samples were exposed to the ambient magnetic field, which was 
measured using a digital Gauss/Tesla meter (model 7010, F.W. Bell, USA) to be 
40.5 ± 2 µT, 59 degrees from horizontal (vertical component = 34.7 ± 2 µT, 
horizontal component = 21.0 ± 2µT). The PRF signal is approved by the US FDA 
for post-operative pain and edema. The signal consisted of a 27.12 MHz 
sinusoidal carrier (derived from the carrier frequency reserved and cleared 
worldwide for short wave diathermy) configured to operate nonthermally through 
pulse modulation in 4 ms bursts, repeating at 5 Hz and peak magnetic field 
amplitude of 10 ± 1 µT (Roma3, Ivivi Health Sciences, San Francisco, CA, USA). 
These pulse modulation parameters were chosen on the bases of theoretical 
modelling and published reports of bioeffects at the cellular level, and healing at 
the animal and clinical levels [1-3, 18-24]. The PRF signal was delivered with a 
20 cm circular single-turn antenna (coil) oriented vertically, creating a 10 x 10 x 5 
cm region of field homogeneity in the central area of the plane of the coil within 
which a plastic carrier held five upright 1.5 mL microfuge tubes, each containing 
1 mL reaction volume. Each Hb sample was contained in a cylindrical volume of 
2.5 cm in height and 0.8 cm diameter. For this target size, using Faraday’s Law of 
Induction, the mean peak induced electric field is 3 ± 1 V/m. PRF field parameters 
were assessed and verified for each experiment using a National Institute of 
Standards and Testing traceable electrostatically shielded loop probe 1 cm in 
diameter (model 100A, Beehive Electronics, Sebastopol, CA, USA) connected to 
a calibrated 100-MHz oscilloscope (model 2012B, Tektronix, Beaverton, OR, 
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USA). The output of the loop probe was calibrated at 27.12 MHz by measurement 
of output power using a spectrum analyser (model 8567A, Hewlett Packard, New 
York, NY, USA) and the probe calibration factor for conversion to magnetic field 
amplitude at 27.12 MHz was certified and given by the manufacturer. SMF 
exposure was delivered using circular permanent ceramic magnets of 3.8 cm 
diameter and 1.3 cm thickness, constructed for therapeutic applications 
(Magnetherapy, West Palm Beach, FL, USA), and composed of compacted and 
sintered strontium ferrite (SrO-6(Fe2O3)), encased in plastic. These magnets are 
axially magnetized to have a single north (N) and a single south (S) pole on each 
circular face, and manufactured to produce highly uniform field strength across 
each face. For all experiments, magnets were arranged with circular faces oriented 
vertically with 1.1 cm gaps between the parallel surfaces. In order to 
simultaneously expose five 1.5 mL microfuge tubes, two 1.1 cm-wide treatment 
regions were formed using a central magnet flanked by pairs of magnets on either 
side. This (NS)(NS)-gap-(NS)-gap-(NS)(NS) configuration produced two 
cylindrical treatment regions of 1.1 cm width and 3.3 cm in diameter with uniform 
magnetic field (to ± 3%), in which the Hb samples were exposed. Within each 
treatment region the horizontal component of the magnetic field (perpendicular to 
the magnet surface) was 186 ± 6 mT, a field strength similar to those commonly 
employed in therapeutic applications [Eccles, 2005]. The maximal value of the 
horizontal and vertical components (both parallel to the magnet surface) was 4.0 ± 
0.6 mT. SMF components were measured using a digital magnetometer (Model 
450, gaussmeter with MMT-6J02-VG transverse Hall effect probe with 1 mm 
resolution, Lake Shore Cryotronics, Westerville, OH, USA). For each experiment, 
five 1.5 mL microfuge tubes containing the hemoglobin preparation were exposed 
to PRF or SMF for 10-30 min, and 5 tubes were simultaneously exposed to 
ambient geomagnetic conditions (control) on the laboratory bench, approximately 
3 meters away from exposed samples. At this distance contributions from either 
PRF or SMF to the control condition were undetectable. Temperature variations 
between exposed and control samples were less than ± 0.1° C [Fisher AB15 
BioBasic, Waltham, MA, USA]. 
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Spectrophotometric Analysis 
After control and EMF exposure, triplicate 300 µL samples were taken from each 
1.5 mL microfuge sample tube, pipetted into an open 96-well flat-bottom plate 
(Fisher Scientific, USA) and the concentrations of oxy, deoxy and metHb were 
measured spectrophotometrically (SpectraMax 190, Molecular Devices, 
Sunnyvale, CA, USA). The plate remained in the spectrophotometer at 22°C 
during the reaction, and the time course of deoxygenation was determined using 
the method of Benesch et al. 1973, which employs a weighted linear combination 
of optical densities at 560, 576 and 630 nm to determine oxyHb, deoxyHb and 
metHb concentrations. Stock Hb solutions (in Hepes, pH 7.2) and spectra from 
Hb/DTT data at t = 0 (i.e. after 30 min EMF/Control exposures) were assayed for 
oxy, deoxy and metHb at 560, 576 and 630 nm [Benesch et al., 1973]. The mean 
ratio of deoxy/oxy for Hb stock solutions was 3.9% ± 0.8%. For the Hb/DTT data 
at t = 0, the mean deox/oxy was 3.3% ± 0.6%. The two datasets do not differ 
significantly (P = 0.44, n = 5). The mean ratio of metHb/oxyHb was 21.8% ± 
3.8% for stock solutions and 25.6% ± 3.7% for Hb/DTT data at t = 0, indicating 
no significant differences (P = 0.33, n = 5). Optical densities at 540, 560, 576 and 
630 nm were measured immediately after EMF exposure and at successive 1 to 30 
min intervals, until maximal deoxygenation was observed. Calibration studies 
confirmed that the kinetics of deoxygenation could be controlled by adjusting the 
ratio of DTT/Hb concentrations [[Herzfeld et al., 1990]]. Under the conditions 
stated above, deoxygenation occurred between 140 and 160 min after EMF 
exposure. Deoxygenation time was reduced by the addition of 5 M of urea to 
between 60-85 min after EMF exposure. In the absence of DTT, no significant 
deoxygenation of Hb occurred up to 3 hours (data not shown). Changes in oxyHB 
concentration with time are summarized in the figures, and maximal differences 
between deoxy and metHb for EMF exposures vs controls are reported in the text. 
All figures and data shown are the results of single experiments that have been 
repeated 2-10 times. 
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RESULTS 
Our early observations of changes in visible light spectra with EMF exposures 
suggested the possibility of a quantitative Hb assay for EMF effect. For example, 
Immediately after 30 min of exposure (PRF: 27.12 MHz carrier, 4 ms bursts at 5 
Hz, 10 µT; SMF: 186 mT), examination of visible light spectra showed that PRF, 
SMF and control (ambient magnetic field only) samples all consisted of 
approximately deoxyHb/oxyHb = 0.03 (see Table 1 for summary). Figure 1, left 
hand plot shows representative visible light spectra for PRF, SMF and control 
exposure conditions, immediately after EMF exposure was removed. Spectra are 
drawn from a single exposure tube for each EMF condition and exhibit the twin-
peaked form characteristic of a low ratio of deoxyHb/oxyHb [Benesch et al., 
1973]. In contrast, changes in visible light spectra were observed in the 540-580 
nm region during the time of most rapid deoxygenation, which occurred in this 
experiment at 140-160 min after EMF exposure, resulting in ratios of 
deoxyHb/oxyHb of about 1.51-1.52 for EMF-exposed samples, as compared to 
0.92 for the control sample (see Table 1). Figure 1, right hand plot shows that the 
spectra corresponding to the PRF-, SMF-treated samples exhibit the characteristic 
spectra corresponding to a higher ratio of deoxyHb/oxyHb, and thus indicative of 
greater oxyHb → deoxyHb conversion for the EMF-treated samples. The molar 
concentrations of oxyHb and deoxyHb are summarized in Table 1 for the spectra 
shown in Figure 1. The results suggest that the PRF and SMF exposures 
employed here could yield a change in the deoxygenation behaviour of the Hb, 
visible several hours after EMF exposures had ended. 
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Figure 1. EMF effect on hemoglobin (Hb) visible light spectra. Spectra 
representative of the effect of pulsed radiofrequency (PRF) signal and 186 mT 
static magnetic field (SMF) on Hb visible light spectra during deoxygenation. 
Data shown are typical of samples drawn from a single tube for each EMF 
exposure condition, shown here at 150 min after a single 30 min EMF exposure. 
Deoxygenation of 100 µM Hb is characterized here by the passage of the 
spectrum from a two-peaked to one-peaked form. Left: At t = 0 min (immediately 
after EMF exposure) the ratio of deoxy/oxy Hb = 0.026 is approximately equal for 
all samples, and indicates nearly complete oxygenation immediately after a 30 
minute exposure to either PRF, SMF or Control = ambient conditions only. 
Right: Deoxygenation occurs at an earlier time for EMF exposed samples (traces 
with one peak), as compared to control samples exposed only to the ambient 
geomagnetic laboratory environment (trace with two peaks). The EMF effect is 
observable at the time of most rapid deoxygenation. The results are summarized 
in Table 1. 
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Table 1. Molar concentrations of oxyHb and deoxyHb for the spectroscopic data 
shown in Figure 1, using the equations of Benesch et al., 1973 to determine the 
molar concentration of oxy- and deoxyHb. These early trials suggested that PRF 
and SMF exposure could result in an increase in the rate of oxyHb → deoxyHb 
conversion, observable several hours after EMF exposure had ended. 
 
In trials employing PRF exposure with multiple tubes (n = 5 tubes for each EMF 
exposure condition) using 20 mM DTT, 150 min after a single 30 min exposure, 
PRF-treated samples exhibited a 30.8 ± 10.3% reduction in oxyHb as compared to 
controls (14.6 ± 1.3 µM vs. 21.1 ± 2.5 µM, P < 0.03) (Figure 2). Concomitant, 
significant increases in deoxy Hb (86.9 ± 1.1 µM vs. 82.8 ± 1.8 µM, P < 0.05) and 
metHb (42.2 ± 1.4 µM vs. 37.1 ± 1.4 µM, P < 0.02) also occurred. (Figure 2). For 
the ratio of DTT/oxyHb concentrations employed in this trial (20 mM DTT; 120 
µM oxyHb), 150 min corresponded to the time of most rapid deoxygenation. 
Addition of 5 M urea to the reagent solution decreased the time to deoxygenate to 
approximately 65-75 min after reaction initiation. For these conditions, the 
maximal difference between PRF-treated and control samples occurred at 73 min, 
with PRF-treated samples showing a 70.5 ± 9.7% reduction in oxyHb as 
compared to controls (8.5 ± 2.1 µM vs. 28.8 ± 6.3 µM, P < 0.03) (Figure 3). 
Concomitantly, there were significant increases in deoxy Hb (54.4 ± 2.2 µM vs. 
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40.9 ± 5.2 µM, P < 0.04) and metHb (73.4 ± 1.4 µM vs. 61.0 ± 2.3 µM, P < 0.02) 
(Figure 3). Under similar conditions (30 mM DTT, 5 M urea, n = 5) SMF treated 
samples (10-30 min exposure) underwent nearly complete deoxygenation before 
the untreated (control) samples began to deoxygenate. For these SMF treated 
samples, the time of most rapid deoxygenation occurred approximately 10 min 
earlier than for control samples (Figure 4), resulting in a 10.7-fold increase in the 
ratio of deoxyHb(PRF)/ deoxyHb(control) (P < 0.002, n = 5). Under these 
conditions, SMF-treated samples have substantially completed DTT-induced 
deoxygenation before untreated samples begin to lose O2, rendering the magnetic 
field effect visibly observable in the 96-well spectrophotometer plate, as shown 
the photo in Figure 5, taken approximately 46 min after the reaction was initiated 
(P-values for these conditions have minima on the order of P = 10-28). 
Experiments were also carried out for which: 1) Hb was treated with PRF or SMF 
for 30 min prior to introduction into the deoxygenation solution (20 mM DTT + 
5M urea in 50 mM Hepes); 2) the deoxygenation solution was treated with PRF or 
SMF for 30 min prior to introduction of Hb. In both cases the difference between 
PRF or SMF treated and control samples was not significant. Also, 10 min vs. 30 
min PRF and SMF treatment durations were compared in 5 M urea, with no 
significant difference observed in the time course of deoxygenation. Trials adding 
100 mM MgCl2 to the deoxygenation solution yielded rapid, 5-7 min 
deoxygenation for SMF-treated samples, as observed visually while samples were 
undergoing SMF exposure. All figures shown here are results of single 
experiments that have been repeated 2-10 times. In the absence of DTT, no PRF 
or SMF effects were observed on the Hb oxidation state. The SMF sensitivity of 
this Hb deoxygenation assay was reconfirmed at the Department of Histology, 
Embryology and Applied Biology, University of Bologna. Initial experiments 
were performed in New York with Hb from a single donor, and subsequent trials 
in Bologna used Hb from 3 different donors, with similar results. 
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Figure 2. Effect of the pulsed radiofrequency field on time course of 
hemoglobin deoxygenation. Time course of oxy hemoglobin (HbO2) 
concentration, after a single 30 min pulsed radiofrequency electromagnetic field 
(PRF) exposure of Hb, under deoxygenating conditions. Concentration was 
determined by visible light spectroscopy at 560, 576, 630 nm. PRF exposure 
resulted in a significant (30.8 ± 10.3)% reduction in oxyHb concentration, as 
compared to controls (14.6 ± 1.3 µM vs. 21.1 ± 2.5 µM, P < 0.03, n = 5), 
suggesting an alteration in Hb solution properties that persisted after PRF signal 
was removed.  
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Figure 3. Addition of 5 M urea to reaction mixture. Addition of 5 M urea to the 
deoxygenation assay reduces the time required for deoxygenation and render the 
PRF effect more apparent. The maximal difference between PRF-treated and 
control samples occurred at 73 min, with PRF-treated samples showing a 
significant (70.4 ± 9.7)% reduction in oxyHb concentration, as compared to 
controls (8.5 ± 2.1 µM vs. 28.8 ± 6.3 µM, P < 0.03, n = 5), in contrast to the 
30.8% reduction observed in the absence of urea (cf. Figure 2). 
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Figure 4. Effect of the static magnetic field on time course of hemoglobin 
deoxygenation. Hb deoxygenation after 10 min exposure to 186 mT static 
magnetic field (SMF) in 5M urea. No significant change in oxy/deoxy ratio was 
visible until the time of rapid deoxygenation, at approximately 40 min. The time 
of most rapid deoxygenation occurred approximately 10 min earlier for SMF 
treated samples (P < 0.002 for 42 min < t < 58 min, n = 5). 
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Figure 5. Reaction plate showing that addition of 5M urea to reaction 
solution renders magnetic field effect more apparent. 96-well 
spectrophotometer plate shown at 46 min after initiation of reaction of 
hemoglobin with dithiothreitol (DTT).  Samples treated for 10 min with 186 mT 
static magnetic field (3 left-hand columns in plate) substantially completed (see 
Figure 4) DTT-induced deoxygenation before untreated samples began to lose O2, 
rendering the magnetic field effect visibly apparent. 
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DISCUSSION AND CONCLUSIONS 
The results from this study indicate that exposure to either PRF or SMF, applied 
independently, can alter the rate of DTT-induced deoxygenation of human Hb in 
an in vitro cell-free preparation, resulting in more rapid conversion of oxyHb → 
deoxyHb. To the author’s knowledge, this is the first report showing that a PRF 
signal, or independently, a SMF could affect similar outcomes in the same 
biological system, in the same study. The rate of oxyHb → deoxyHb conversion 
is non-linear in time and is dependent upon the ratio of DTT/HbO2. For this assay, 
the use of DTT as a reducing agent is preferable to other reducing agents, due to 
the ease with which the time to deoxygenation can be controlled [Herzfeld et al., 
1990]. It is interesting to note that a similar EMF sensitivity, for Hb exposed to a 
GSM mobile phone signal, was observed using sodium dithionite [Mousavy et al., 
2009]. This suggests that the action of the EMF is upon a functional aspect of the 
Hb deoxygenation process itself, and not specific to the reducing agent employed 
in this study. The observation that EMF pre-treatment of Hb alone, or the 
deoxygenation solution itself, failed to yield a significant PRF or SMF effect 
suggests that both the electric and magnetic fields act upon the interaction of Hb 
with the deoxygenating solution. The addition of 5 M urea reduced the time to 
deoxygenate and rendered the both the PRF and SMF effects more easily 
observable. Urea creates an extended cloud of waters that only weakly participates 
in the hydrogen bonding network of bulk water, facilitating the loosening of the 
protein structure [Roche et al., 2006] and destabilizing the water-oxyHb structures 
that act as key allosteric mediators of the Hb T-R transition [Royer et al., 1996], 
thus reducing the energy required to deoxygenate. However, it is unclear whether 
the addition of urea affected the primary PRF or SMF transduction or merely 
renders the EMF effects more easily observable. No differences were observed 
between 10 and 30 min SMF and PRF treatment durations. Effects were 
observable several min to several hours after PRF or SMF exposure was removed, 
suggesting that the induced electric field and/or static magnetic field modifies 
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protein/solvation structure in a manner that alters the energy required for the oxy-
deoxy conformational change.  
 
This study does not provide sufficient evidence to allow details of the EMF 
mechanisms of action to be elucidated, or to determine if SMF and PRF act upon 
the same submolecular targets to produce the effects observed here. However, the 
sensitivity and biochemical simplicity of the assay developed here suggest a new 
tool that may help to further establish basic biophysical EMF transduction 
mechanisms. Several models have been proposed for weak, µT-range magnetic 
field bioeffects [Binhi et al., 2007], and a recent model has been proposed for the 
interaction of the PRF signal employed here with ion binding sites at a protein’s 
aqueous interfaces via the induced electric field [Pilla et al., 2011]. PRF 
transduction via the induced electric field is distinct from the transduction 
pathway involved in SMF effects, for which no electric field is present, suggesting 
that more than one mechanism may be responsible for the results reported here. 
Although direct action on the ferrous heme site [Pauling, 1977] and free radical 
lifetimes may contribute to the SMF effects observed here [Closs 1969; Timmel et 
al., 1998], we have previously shown via the Lorentz-Langevin model that µT-
range magnetic fields may have an effect on the orientation of ionic oscillators 
and waters bound at the protein surface [Muehsam et al., 2009a, 2009b] and that 
the minimum magnetic field required to directly compete with thermal forces to 
affect dissociation of a bound ion or ligand from a protein binding site is in the 1-
10 mT-range [Muehsam et al., 1996]. Thus, the effect of the mT-range magnetic 
field employed in this study could occur via the direct action of the Lorentz force 
on charges bound at the protein/water interface. Functionally important 
hemoprotein molecular motions are slaved to the thermal fluctuations of the bulk 
solvent [Frauenfelder et al., 2009] and protein hydration plays a fundamental role 
in the stability of dynamics between Hb T-R conformations [Salvay et al., 2003], 
so that the PRF and SMF interactions described above, acting at the protein/water 
interface, may suggest a means by which EMF could modulate protein function. 
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The deoxygenating conditions employed here, using the reducing agent DTT in an 
in vitro cell-free model, differ substantially from those found in vivo. However, 
the EMF-induced changes in structure and function of Hb and erythrocyte 
suspensions listed above [Tao et al., 2011; Sosa et al., 2005; Shalaby et al., 2006; 
Sakhnini et al., 2001; Iwasaka et al., 2001; Milweski et al., 2006; Magazù et al., 
2009] occurred either in vivo or in aqueous solution, in the absence of 
deoxygenating agents, thus demonstrating an EMF sensitivity under physiological 
conditions and in the absence of reducing agents. Enhanced delivery of oxygen 
has been shown to reduce inflammation [Bitterman, 2007] and enhance tissue 
repair [Tandara et al., 2004] and at least one trial has reported an EMF-induced 
increase in deoxyHb in an in vivo animal model [Milweski et al., 2006]. Allosteric 
modification of Hb has been suggested as a clinically useful means of enhancing 
oxygen delivery [Papassotiriou et al., 1998], and is in development for in vivo 
treatment of ischemia from stroke, cardiac disease and diabetic ulcers [Najjar et 
al., 2005]. Well-known interactions of NO with hemoprotein transition metals 
[Ignarro et al., 1986; Thomas et al., 2003; Bonaventura et al., 2001] and recent 
results clearly demonstrating regulation by endothelial Hb alpha of the action of 
NO on vascular reactivity at the myeloendothelial junction [Straub et al., 2012] 
and the in vivo modulation of Hb oxygen affinity by NO synthase [Zinchuk, 1999] 
may also suggest that the molecular dynamics exhibited by hemoproteins 
[Frauenfelder et al., 2009] play an important role in EMF-mediated regulation and 
maintenance of biological growth and repair processes. Although much further 
work is required to ascertain the clinical relevance of the results reported here, if 
an EMF-induced increase in the rate of deoxygenation can be demonstrated in 
vivo, then a resulting enhancement of oxygen delivery may be an important non-
invasive, non-pharmacologic therapeutic method by which clinically relevant 
EMF-mediated enhancement of growth and repair processes can occur.  
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b. EMF EFFECTS ON HEMOGLOBIN STRUCTURE AND FUNCTION: 
PYRANINE FLUORESCENCE AND GADALINIUM3+ VIBRONIC 
SIDEBAND SPECTROSCOPY, INFRARED SPECTROSCOPY, 
HEMOGLOBIN OXYGEN SATURATION 
 
 
INTRODUCTION 
Upon discovery of the EMF sensitivity of the Hb deoxygenation assay, 
collaborations were sought in order increase the understanding of the underlying 
mechanisms. I had the good fortune to be invited to work in three laboratories 
with expertise and instrumentation in protein structure and function. 
Pyranine fluorescence and gadolinium vibrionic sideband luminescence 
spectroscopy was conducted at the Department of Physiology and Biophysics, 
Division of Cardiovascular Physiology, Albert Einstein College of Medicine, 
Bronx, NY, under the direction of Drs. Joel Friedman and Camille Roche. Drs. 
Friedman and Roche are expert in the biophysics of Hb and protein/solvent 
interactions. Discussions with Dr Friedman led to the introduction of 5M urea to 
the Hb deoxygenation assay, resulting in the marked increase in the repeatability 
and observability of EMF described in the previous Chapter. We hypothesized 
that the structuring of water, as evidenced by the effect of solvent structure on the 
stability of proteins in solution [Fonseca et al., 2006; Roche et al., 2006] could 
play a role in the mediation of EMF effects on Hb. Under excitation at 355 nm, 8-
hydroxy-1,3,6-pyrene trisulfonate (HPT) manifests a characteristic fluorescence 
spectrum in the 400 – 600 nm region, providing information regarding the relative 
amount of mobile and immobile waters (ns time scale) [Royer et al., 1996; Gow et 
al., 2005]. The Gd3+ vibronic sideband luminescence spectra, in the 342 nm region 
under 273 nm excitation, reflects hydrogen bond strength between 1st and 2nd 
shell waters relevant to protein stability [Guo et al., 2009]. Thus, both of these 
techniques yield information regarding the structuring of waters acting as key 
allosteric mediators of Hb function [Royer et al., 1996; Salvay et al., 2003]. 
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A second collaboration was initiated at the School of Pharmacy and 
Pharmaceutical Sciences, Trinity College, Dublin, Ireland, under the supervision 
of Dr. Astrid Sasse, using attenuated total reflection (ATR) Fourier transform 
infrared (FTIR) spectroscopy to study the changes in protein structure on Hb 
structure [Jung, 2000] due to EMF exposure. Dr. Sasse and her staff have 
expertise in the FTIR spectroscopy and its use in the identification of protein 
structure and characterization of pharmacological compounds. ATR-FTIR 
spectroscopy is recently developed set of techniques that obviates some of the 
difficulties inherent in the short path lengths required transmission FTIR for 
aqueous samples, and allows for the analysis of a wide range of materials in 
liquid, solid and powdered forms [Smith et al., 2002]. Previous effects reported 
due to EMF exposures of Hb and human serum albumin [Magazu et al., 2010, 
2011] suggested that EMF-induced changes in Hb structure could be observable 
using ATR-FTIR methods. 
 
In addition, the effect of a SMF on Hb equilibrium oxygenation saturation (SO2) 
was assessed at the Laboratory of Biochemistry and Molecular Biology, Ospedale 
San Paolo, Milano, under the direction of Drs. Michele Samaja and Rosaria 
Russo. Dr. Samaja’s expertise is in biochemistry and physiology and is 
recognized as a leading expert in Hb biochemistry and hematology. This study 
addressed the issue of the clinical relevance of the EMF effect found in our 
deoxygenation assay by using a partial pressure method [Bohr et al., 1904] to 
determine if a SMF could directly alter SO2. We hypothesized, based upon 
observations of changes of Hb oxygen affinity due to EMF exposures [Shigina, 
2002; Mousavy et al., 2009], that a SMF might alter the oxygen saturation SO2 of 
Hb in a solution held at partial saturation in a gas-controlled environment.  
 
 
MATERIALS AND METHODS 
HPT Fluorimetry and Gd3+ Vibronic Sideband Spectroscopy: Stock solutions of 
the HPT probe were prepared according to the methods of [Roche et al., 1996]. 
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Buffer solutions were degassed with nitrogen for 30 min, then deoxy-Hb was 
prepared from a 100 µM (heme) solution of oxy-Hb (in degassed buffer: 0.05 M 
BisTris OAc or 50 mM Hepes, pH 7.2) by adding sodium dithionite (2X heme) to 
deoxygenate. HPT was then added to the resulting deoxy-HbA solution in a ratio 
of 1:1 (per molecule, in Hb tetramer, 0.25 heme concentration, per volume = 
3:1000, resultant Hb concentration = 100 µM due to mM-range concentration of 
HPT probe). All solution preparation was performed in a nitrogen atmosphere, 
and cuvettes were sealed throughout all experiments. Fluorescence spectra were 
obtained at 1 nm resolution using a modular PTI Fluorescence system (Photon 
Technology Inc., Lawrenceville, NJ). Spectra were generated using the following 
experimental settings: an excitation wavelength of 355 nm, 1-mm slit width for 
excitation and emission slits, and an integration time of 0.5 or 1 s at ambient 
temperature = 22° C. Samples were placed in an optical cuvette with 1-mm path 
length, with the instrument configured for front face emission [Hirsch et al., 
1994]. The integrity of the protein was verified by visible light spectroscopy 
before, during, and after experimental procedures, to ensure that the ligation state 
of the heme did not change during the time course of the experiment. Gadolinium 
vibronic side band luminescence spectra were measured at 0.25 nm resolution in a 
QuantaMaster model QM-4/2000SE enhanced performance scanning 
spectrofluorometer (Photon Technology International, Lawrenceville, NJ). The 
Gd3+ concentration in all probed solutions was 100 mM. Samples were held in the 
quartz cuvette and placed in the sample chamber in the configuration for 90° 
excitation. The emission profiles were recorded with the excitation of 273 nm, and 
luminescence was recorded from 290 to 400 nm. The step size was set to 0.25 nm. 
Each spectrum measurement was repeated at 10-25 times and averaged. For 
experiments with EMF exposures, samples were placed into two cuvettes, and 
immediately subjected to spectrographic measurement. EMF treated samples were 
exposed for 15-30 min to either the ambient geomagnetic field, or ambient plus a 
SMF generated by permanent ceramic magnets to produce an amplitude of 150 
mT (Magnetherapy, West Palm Beach, FL). 15-30 min exposures were also made 
using a 27.12 MHz PRF (Ivivi Health Sciences, LLC, San Francisco) transmitted 
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in 4 ms bursts, repeating at 5 Hz (PRF). Both EMF-exposed and control samples 
were covered with optical cloth to shield fluorescence probes from light 
contamination. Sample spectra were collected immediately after 15 min and 
measured again at subsequent 15 min intervals. In order to have the ability to 
observe the relative change of two spectral peaks, initial trials with the HPT probe 
were performed in 50% glycerol. Subsequent trials added 100 mM MgCl2 [Feng, 
2009] to 50% glycerol, or used 5 M urea, in either Tris or Hepes buffers, and also 
observed the time series of Hb deoxygenation in 30 mM dithiothreitol (DTT) in 
50 mM hepes buffer. Trials using Gd3+ employed only SMF exposures. All 
experiments were controlled at pH 7.2. Infrared Spectroscopy:  Stock solutions of 
1 mM human Hb in 50 mM Hepes (pH 7.2) or Hepes + 5M urea were divided into 
1 mL aliquots in sealed 1.5 mL Eppendorf tubes. 5 tubes were designated as 
controls, exposed only to ambient conditions in the laboratory and 5 tubes were 
designated to be EMF treated for 3 – 21 hrs to either the ambient field, or ambient 
plus a 150 mT SMF generated by permanent ceramic magnets. All controls and 
samples were at the same 23° C temperature, approximately 3 m distant on the 
same lab bench. Exposures were also made using a 10 µT, 27.12 MHz pulse-
modulated radiofrequency EMF (Ivivi Health Sciences, LLC, San Francisco) 
transmitted in 4 ms bursts, repeating at 5 Hz. ATR-IR spectra of samples were 
analysed (Perkin Elmer Spectrum One infrared spectrophotometer with ATR 
accessory) immediately after EMF treatment. 30 µL aliquots from each tubes 
were placed in the ATR assembly and spectra from each tube were recorded 10-
25 times and then averaged by the spectrophotometer software. After averaging 
the Hb spectra, the solvent spectrum, similarly averaged, was then subtracted 
[Barth, 2007; Damian et al., 2005]. Spectra were compared for Hb samples 
exposed to the PRF and SMF conditions for durations of 3 – 21 hrs. Hemoglobin 
Oxygen Saturation: A specialized apparatus consisting of a glass chamber joined 
smoothly to an optical cuvette was employed for observing 
spectrophotometrically the oxidation state of hemoglobin (Arbore Cataldo 8NC, 
Milano, Italy), see Photo 1. Nitrogen gas passed through the chamber for 30 min 
and then the chamber was sealed. Total chamber + cuvette volume 159.19 mL. 1 
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mL of hemoglobin solution consisting of 0.5 mM Hb in PBS was injected into the 
chamber and mixed smoothly for 10 min to allow for deoxygenation. The ratio of 
oxyHb/deoxyHb (SO2) was determined via the method of Benesch et al., 1973, 
from the optical densities optical densities at 540, 560 and 576 nm. After 10 
allowing min for equilibration SO2 was = 0.048 ± 0.01. To raise SO2, 7.5 mL of 
air was injected into the cuvette, resulting in a stable value of SO2 = 0.32 ± 0.001. 
All changes in SO2 required gentle manual mixing of the Hb sample within the 
chamber portion of the chamber/cuvette assembly. After mixing, the apparatus 
was held in an upright position to allow the Hb sample to flow into the optical 
cuvette. SMF exposure was made by sandwiching the optical cuvette between 5 
ceramic magnets placed in a pole-assisting configuration, producing a SMF of 
approximately 150 mT inside the cuvette. The Hb solution was exposed for 10 
min, then the magnets were removed and the cuvette placed as quickly as possible 
into the spectrophotometer. Measurements of SO2 were made using optical 
densities at 540, 560 and 576 nm, immediately after placing the cuvette in the 
spectrophotometer (time = 0) and at 1, 2, 3, 9, and 11 min later. A second 10 min 
SMF exposure was made, and measurements take immediately post-exposure and 
30, 90, 150, and 210 s later. Calibration experiments performed using DTT to 
deoxygenate Hb in an optical cuvette showed that only portion of the sample at 
the top of the optical column underwent deoxygenation, indicating that exposure 
of the sample to air was in fact necessary to initiate deoxygenation (data not 
shown). Assessment of the effects of handling the gas chamber/cuvette were also 
made by performing measurements at 2 min intervals before and after gently 
mixing the Hb sample in the chamber portion of the apparatus and then allowing 
positioning the apparatus such that the Hb sample flowed back into the cuvette. 
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Photo 1: Specialized device for measuring Hb SO2 under gas-controlled 
conditions. Chamber was evacuated and oxygen replaced with nitrogen gas, and 
Hb then injected into chamber and thus deoxygenated. SO2 could be controlled by 
injecting aliquots of oxygen into the chamber Left: SO2 assessed 
spectrophotometrically with liquid sample in cuvette region at bottom of device. 
Right: Magnetic field exposure was performed by placing magnets on either side 
of cuvette region. Magnets were held in place by pole-assisting configuration. 
  
 
RESULTS 
HPT Fluorimetry and Gd3+ Vibronic Sideband Spectroscopy: No differences in 
fluorescence spectra were observed between control and both SMF- and PRF-
treated samples for the HPT probe in 50 mM BisTris OAc, at pH 7.2, or with the 
addition of 5 M urea, 50% glycerol or 10 mM MgCl2, thus confirming the 
viability of using this method for assessing EMF effects on protein/hydration 
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structure. For our first trials, glycerol was chosen as a solvent due to the 
characteristics twin-peak spectrum in the 450 - 510 nm region, allowing for 
assessment of the ratio of two peaks, rather than the single 510 nm peak [Roche et 
al., 2006]. For 30 min SMF exposures of 100 µM deoxyHb in 50% glycerol, no 
changes were found in spectra for control vs. SMF exposures, as shown in Figure 
1, left hand plot. Spectra shown are normalized to height of peak at 510 nm. For 
these conditions, the maximum difference in F/Fo for SMF exposures of 0.019 
was one the same order of maximal difference of 0.021 observed for the untreated 
control from same stock solution. Figure 1, right hand plot shows similar results 
with the addition of 100 mM MgCl2 [Guo et al., 2009], also in 50% glycerol, and 
again no differences between SMF and control exposure was observed. For these 
conditions, the maximum difference in F/Fo for SMF exposure of 0.018 was less 
again than the maximal difference of 0.045 observed for the untreated control 
from same stock solution. These trials were repeated a 2nd time, with similar 
results, and the decision was made not to perform further repetitions. In order to 
test the hypothesis that an EMF effect might be rendered more visible through the 
addition of urea to the solution, trials were performed using 30 min SMF exposure 
of 100 µM deoxyHb in 5M urea using 50 mM Tris buffer under the same 
conditions as the previous experiment. The results, shown in Figure 2 let hand 
plot, again showed no changes in spectra between pre- and post-SMF exposures. 
For these conditions, the maximum difference in F/Fo for SMF exposures of 0.018 
was on the same order of the maximal difference of 0.012 observed for the 
untreated control from same stock solution. Similar trials were performed in this 
reaction mixture, using a 30 min PRF exposure. The results, shown in Figure 2, 
right hand plot, again showed no differences between PRF exposed and control. 
For these conditions, the maximum difference in F/Fo for PRF exposure of 0.016 
was on the same order of the maximal difference of 0.012 observed for the 
untreated control from same stock solution. These trials were also repeated, again 
with similar results, and the decision was made not to perform further repetitions. 
For all the trials with Hb in the HPT probe, the normalized spectra are pixel-for-
pixel identical, as can be seen in Figures 1 and 2. Similar trials were performed 
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using 50 mM Hepes buffer, pH 7.2, but substantial variability in amplitudes of 
spectra were observed, which changed with time and mechanical agitation of the 
solutions. Difficulties encountered with Hepes buffer had been previously 
observed and attributed to an interaction or ‘stacking’ of the ring structures of 
Hepes and the HPT probe [Dr. Camille Roche, personal communication, 2012]. 
Similar experiments were performed for Gd3+ vibronic sideband spectra, using 
100 µM deoxyHb in 5M urea, again in Tris 50 mM Tris buffer, pH 7.2. As shown 
in Figure 3, left hand plot, the Gd3+ spectra showed no differences between before 
and after a 30 min SMF exposure. For these conditions, the maximum difference 
in F/Fo for SMF exposure of 0.024 was on the same order of the maximal 
difference of 0.021 observed for the untreated control from same stock solution. 
Figure 3, right hand plot, shows the behaviour of the untreated control sample 
after 30 minutes, illustrating that the slight broadening of the peak occurred for 
controls as well as SMF treated samples (to better illustrate this, Figure 3 is 
presented with symbols on the data points, rather than using lines as in the 
previous Figures). For these conditions, the maximum difference in F/Fo of 0.024 
for the untreated control from same stock solution after 30 min was on the same 
order of the maximal difference of 0.021 upon initial registration of the spectrum. 
For these experiments using Gd3+ spectra, the peak of the vibronic sideband 
spectrum always occurred either at 341.75 or 342.00 nm. These trials were 
repeated for 30, 60 and 90 min SMF exposures, with similar results, and the 
decision was made not to perform further repetitions.  
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Figure 1. Left: HPT fluorescence spectra for 100 µM deoxyHb in 50% glycerol 
and 50 mM Tris buffer, pH 7.2, for control and SMF exposed samples, shown 
before and after a 30 min SMF exposure. Spectra read immediately after SMF 
exposure show no differences between exposed and control samples. Right: 
Similar results were found with the addition of MgCl2 to the Hb solution.  
 
 
Figure 2: Left: HPT fluorescence spectra for 100 µM deoxyHb in 5 M urea and 
and 50 mM Tris buffer, pH 7.2, for control and SMF exposed samples, shown 
before and after a 30 min SMF exposure. Spectra read immediately after SMF 
exposure show no differences between exposed and control samples. Right: 
Similar results were found with 30 PRF exposure using the same reagent mixture.  
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Figure 3. Left: Effect of 30 min 150 mT SMF exposure on Gd3+ vibronic 
sideband spectra, using 100 µM deoxyHb in 5M urea and Tris 50 mM Tris buffer, 
pH 7.2. Results show no effect of SMF exposure on vibronic sideband structure 
indicative of hydrogen bonding strength between 1st and 2nd shell hydration layers. 
Right: Vibronic sideband spectra of untreated sample, from same stock solution, 
illustrating the slight broadening with time of the sideband peak, which occurred 
for both SMF-treated and untreated controls. Results show no changes due to 
SMF exposure, after field is removed. 
 
 
Infrared spectroscopy: The Perkin Elmer ATR apparatus employed here produced 
repeatable spectra of Hb in solution corresponding to those found previously 
[Magazu et al., 2010] that allowed for the discrimination Hb contribution to IR 
spectra above that of the solvent. For example, calibration experiments showed 
that the double peak in the Amide A band in the 3400 – 3200 cm-1 region was 
clearly resolved (data not shown), in accord with without requiring the use of 
curve-fitting or iterative methods such as concave rubberband corrections 
[Magazu et al., 2010]. Of particular interest are the Amide I–VI peaks in the 1700 
- 1000 cm-1 region, used most commonly for investigating the secondary structure 
of proteins [Van deWeert et al., 2005]. For a 3 hr SMF exposure, in 50 mM Hepes 
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buffer, pH 7.2, Figure 4, left hand plot shows the IR transmittance spectra in the 
Amide I-II band, for the average of 5 tubes for exposed and control samples, after 
subtraction of the solvent contribution, normalized to the height of the Amide II 
peak (largest peak). An apparent difference in transmittance across the spectrum 
suggest an effect of the SMF exposure, and the change is significant in the 1580 – 
1607 nm Amide Amide I-II region (P < 0.05, n = 5). Figure 4 right hand plot 
shows the data from the repetition of this same experiment, where significant 
changes in transmittance occurred also in the Amide I-II region (P < 0.03, n = 5). 
However, the change in amplitude occurs in the opposite direction for SMF-
exposed and untreated samples. Also, changes in the width of the Amide I and II 
bands were also in opposite directions for these 1st and 2nd trials. In addition, 
although for each these two trials there is a change in the ratio of Amide I-II as 
compare to Amide III-VI, these ratios also change in opposite directions for the 
two trials. Both the normalized and un-normalized spectra exhibit these changes 
in amplitudes between the two trials. Thus, the difference spectra, a fingerprint of 
conformational change [Barth, 2007] have amplitudes in opposite directions for 
these experiments, again suggesting that any changes in amplitude that might have 
occurred due to SMF exposure were smaller than the variability of the assay itself. 
Analogous results hold for the 2nd derivative spectra of smoothed data and for the 
above analyses of the Amide A band in the 3400 – 3200 cm-1 region. In response 
to these data, and in hopes of magnifying EMF sensitivity, as in the Hb 
deoxygenation assay, we conducted further trials with 5M urea added to the Hb 
solution. The stability of the IR spectra was much greater with the addition of 5 M 
urea, allowing for repeatable measurements (Figure 5). It is of interest to note the 
marked smoothing of the spectrum of the protein in 5M urea, and appearance of a 
characteristic peak at approximately 1150 cm-1, corresponding to changes in the 
hydrogen bonding behaviour of the solution [Barth, 2007; Roche, et al., 2006], as 
can be seen in Figure 5. Figure 5, left hand plot shows the Amide I–VI region for 
a 30 min SMF exposure, as compared to the unexposed control. No significant 
differences in transmittance occur throughout the Amide I-IV region (P > 0.53, n 
= 5). Figure 5, right hand plot show the same conditions for a 60 min  PRF 
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exposure. Again, no significant differences in transmittance occur throughout the 
Amide I-IV region (P > .21, n = 5). For both SMF and PRF exposures, the 
transmittance varied by less than 0.5% at all points in the Amide I-VI region. 
Similar results held for these trials in the Amide A band.  
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Figure 4: Repetition of experiment shows assay variability in IR transmittance 
spectra, for Hb in 50 mM Hepes buffer, pH 7.2, i.e., in the absence of urea. Left: 
Normalized infrared spectra of the Amide I-VI region, used most commonly for 
investigating the secondary structure of proteins, of Hb FTIR spectra for 30 
minute SMF exposure, as compared to unexposed samples, with solvent sample 
subtracted. Apparent change in amplitude across the Amide I-VI region suggests 
an SMF effect. Right: Repetition of first experiment shows mean amplitude 
changed in opposite direction, suggesting that any putative SMF effect is smaller 
than the experimental error of our assay. Note that, as shown below, the addition 
of urea greatly stabilizes the Hb IR spectra. 
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Figure 5. Left: Normalized infrared transmittance spectra of the Amide I–VI 
region for 30 min SMF exposure of 1 mM Hb in 5M urea and 50 mM Hepes 
buffer, pH 7.2. No significant differences in transmittance occur throughout the 
Amide I-IV region (P > 0.53, n = 5). Right: Normalized spectra of 1 mM Hb in 
5M urea and 50 mM Hepes buffer, pH 7.2for 1 hr PRF exposure, with the same 
reagent mixture. Again, no significant differences in transmittance occur 
throughout the Amide I-IV region (P > .21, n = 5). Both experiments were 
repeated with similar results. 
 
 
Hemoglobin oxygen saturation: Measurements of SO2 according to the time series 
described in the Methods section are shown in Figure 6.   95% confidence 
intervals are shown using dotted lines, and the solid line is a linear regression on 
the data (Rsqr = .24). The results show that changes in Hb SO2 due to 10 min 
SMF exposures were within the variability of the time series examined, as shown 
in Figure 6, left hand plot. Figure 6, right hand plot shows that changes in SO2 
due to removing the chamber/cuvette device from the spectrophotometer were 
also within the variability of the time series data (Rsqr = .83). However, 
comparison of the two plots in Figure 6 shows that the effects of mixing were on 
! +)
the same order of greater than those observed after SMF exposure. As a result of 
these observations, the choice was made to discontinue these experiments. 
 
 
 
Figure 6. Left: Time series of Hb SO2 with two 10 min SMF exposures. Changes 
in SO2 after SMF exposure are within the variability of the assay. Right: 
Variability of Hb SO2 assay, with mixing and gentle shaking of sample. Results 
show that variability due to handling is on the same order as variability due to 
SMF exposures, and suggest that a more sophisticated apparatus is needed to 
allow for mixing and the addition/removal of EMF devices. 
 
 
 
DISCUSSION AND CONCLUSIONS 
The HPT probe was shown to be insensitive to EMF in Tris buffer, suggesting its 
use for assessment of EMF effects in protein solution. HPT fluorescence 
spectroscopy showed no effects on Hb in Tris buffer, suggesting that exogenous 
EMF does not alter the relative amount of mobile and immobile waters on a ns 
time scale, in solution. Observed EMF effects on Hb deoxygenation could thus be 
due to an effect on protein internal structure, rather than allosteric mediation of 
oxy/deoxy conversion by solvation structure. The instability of HPT spectra in 
hepes suggests that this buffer is not suitable for assessing water structure with 
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HPT or Gd3+. The short ns-scale relaxation time of water polarization [Royer et 
al., 1996], and instability of the Gd3+ assay suggests the need to generate EMF 
exposure directly inside the spectrophotometer. The consistency of the negative 
results found for the ATR-FTIR experiments suggest that under the conditions 
employed here, no significant changes in spectra occurred. In the absence of urea, 
the Hb FTIR spectra showed greater variability than apparent changes due to SMF 
exposure. Furthermore, the close correspondence of the control and EMF-treated 
difference and derivative spectra (P > 0.53, n = 5 for all experiments) in the 
presence of urea (which greatly enhanced EMF effect on DTT-induced 
deoxygenation), suggests that ATR-FTIR spectra do not reflect that changes in Hb 
solution properties that occurred in the presence of DTT. The results clearly 
obviate the use of deconvolving techniques, whose purpose is to render more 
information regarding specific frequencies at which significant spectral changes 
occur [Van deWeert et al., 2005]. Variations in Hb SO2 after SMF exposure were 
on the same order as the variability due to mixing in the chamber/cuvette 
assembly. Because manual mixing is required to stabilize SO2 after modifying gas 
pressure, and deoxygenation in the optical cuvette required exposure to the 
ambient gaseous environment, it is insufficient to expose the Hb in the restricted 
volume of the optical cuvette. This, suggests the need to develop a specialized 
device that allows a constant perfusion of the Hb sample through the gaseous 
environment during EMF exposure. 
 
Although the studies performed here were unable to detect EMF-induced changes 
in Hb structure and function, further development of the techniques used here may 
provide insight into the biophysical mechanisms responsible for the EMF effects 
we observed in DTT/Hb deoxygenation. Because of the short lifetimes of the 
substates of the Hb T-R transition [Hub et al., 2010], and brief relaxation times of 
protein conformations and hydration structures [Royer et al., 1996; Juszczak et al., 
1999], it is possible if EMF effects occur during field exposure, these are rapidly 
stabilized upon removal of the field exposure. Thus, the three studies undertaken 
here collectively suggest the necessity of real-time exposure systems to assess 
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EMF effects on Hb structure and function. Specialized equipment for single-
wavelength excitation and detection of fluorescence and vibronic sideband spectra 
could be constructed. Non-metallic fiber-optic techniques would allow detection 
of spectra, while EMF generation occurred during excitation. Similarly, a non-
metallic ATR-FTIR device could be constructed to allow real-time assessment of 
IR spectra during EMF exposure. Indeed, a relatively new technique for providing 
rapid, noninvasive and reliable in vivo estimation of Hb SO2, using laser Raman 
spectroscopy [Torres Filho et al, 2008] may be adaptable to real-time in vivo EMF 
exposures. 
!
!
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4.THEORETICALMODELLING


a. LORENTZ MODEL FOR MAGNETIC FIELD BIOEFFECTS: 
APPLICATION TO BOUND WATERS VIA GIBBS FREE ENERGY AT 
SURFACE OF A BIOMOLECULE; CORRESPONDENCE TO 
PREDICTIONS OF ION PARAMETRIC RESONANCE MODEL 
 
 
INTRODUCTION 
The mechanisms by which extremely low frequency (ELF) microTesla-range 
magnetic fields can directly influence biological processes are now coming under 
clearer review [Milyaev et al., 2006; Binhi et al., 2007; Machlup, 2007; Muehsam 
et al., 2009a]. Early speculations that ion and ligand binding may serve as primary 
transduction pathways for DC and ELF magnetic field effects [Bawin et al., 1975, 
1976; Blackman et al., 1982; Smith, 1987; Liboff et al., 1987, 1988, 2003; Lednev, 
1991; Chiabrera et al., 1985, 1992; Edmonds, 1993; Muehsam et al., 1994, 1996; 
Pilla et al, 1997] have been supported by further evidence of well-defined 
resonance frequencies [Zhadin et al., 1998; Zhadin 1990; Pazur 2004] and 
supported by additional theoretical modelling [Ramundo-Orlando et al., 2000; 
Zhadin et al., 2005; Binhi et al., 2007; Muehsam et al., 2009a, 2009b]. Ca2+/CaM 
binding serves as a model ion binding pathway for the consideration of models for 
ELF magnetic field effects. In addition to the experimental evidence supporting 
EMF effects on systems modulated by this pathway [Shuvalova et al., 1991; Bull 
et al., 1993; Markov et al., 1992, 1993, 1997; Liboff et al., 2003], Ca2+/CaM 
binding possesses biochemical and biophysical properties that suggest it as a 
likely EMF-sensitive target. Ca2+/CaM binding is kinetically asymmetrical, i.e., 
the rate of binding exceeds the rate of dissociation by several orders of magnitude 
(kon >> koff), driving the reaction in the forward direction. Ca2+/CaM binding has 
been well characterized, with the binding time constant reported to be in the range 
of 10-2-10-3 sec [Blumenthal and Stull, 1982]. In contrast, release of Ca2+ from 
CaM cannot occur until cNOS has converted L-arginine to citrulline and NO, 
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which takes the better part of a second [Daff, 2003]. Thus, the time scale for 
binding is too short for effects due to weak, ȝT-range magnetic fields, which 
generally require a target lifetime on the order of the Larmor or cyclotron period, 
measured in hundreds of ms for ELF exposures [Lednev, 1991; Binhi 2002; 
Muehsam et al., Muehsam et al., 2009a, 2009b]. Thus, the long bound lifetimes on 
the order of 1 s observed for Ca2+ binding to CaM  [Cox, 1988; Daff, 2003] 
suggest a physically reasonable target for weak ELF magnetic field interactions. 
 
One of the challenging aspects of formulating theoretical models for weak ELF 
magnetic field bioeffects has been the so-called ‘kT-Problem’ [Binhi et al., 2007; 
Machlup, 2007]. The ‘kT-Problem’ refers to the difficulties inherent in the 
formulation of models for ELF interactions for which the molecular energy of 
interaction is less than that of the mean thermal noise. In the light of the large and 
steadily growing body of such nonthermal EMF bioeffects, a number of 
theoretical models have been developed describing thermal noise limits for EMF 
interactions [Weaver et al., 1990; Chiabrera et al., 1992; Edmonds, 1993; 
Muehsam et al., 1994, 1996; Binhi et al., 2003, 2007; Machlup, 2007]. A more 
detailed description of several of these models for weak ELF magnetic field 
effects may be found in one of my more recent publications [Muehsam et al., 
2009a]. This ‘kT-Problem’ has also led to some controversy, and even to attempts 
to argue against the existence weak ELF effects on theoretical grounds [Adair, 
1991, 1997], despite the experimental data at hand. However, despite the 
controversy, there is a large and continually growing body of experimental 
evidence that weak ELF magnetic fields can cause bioeffects [Bersani, 1999; 
Binhi, 2002], and the results, taken collectively are difficult to dismiss out of 
hand. Interestingly, and perhaps not so well-known to scientists in the West, is the 
more than 130 years of research into bioeffects of static and low-frequency 
magnetic fields documented in Russia and the former Soviet bloc [Zhadin, 2001]. 
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THE LORENTZ MODEL 
In response to the ‘kT-Problem,’ my earlier publications suggested that, rather 
than posing an obstacle to EMF detection, thermal noise forces could play an 
essential role in the detection of magnetic field [Muehsam et al., 1994, 1996; Pilla 
et al, 1997]. To summarize briefly the basics of the model from Muehsam et al., 
2009a, the Lorentz-Langevin equation of motion for a charged species such as an 
ion or ligand bound in a binding site represented by a harmonic oscillator 
potential, subject to a DC magnetic field oriented up along the z-axis, and in the 
presence of thermal noise is [Chiabrera et al., 1992]: 
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dt2
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dt
J dr
dt
uBo
ª
¬«
º
¼»kZ
2r n   (1) 
 
Where r is the position vector of the particle; ȕ is the viscous damping coefficient 
per unit mass (due to molecular collisions in the thermal bath), Ȗ is the target 
charge-mass ratio; Bo is the magnitude of the magnetic field vector; k is the unit 
vector along the z-axis; Ȧ is the angular frequency of the oscillator and n is the 
stochastic thermal noise force vector per unit mass.  
 
A closed form solution to Equation 1 may be found, and adopting the notation of 
Chiabrera et al., 1992, in the complex plane, the thermal component of the motion 
P(t) is given by: 
 
)(tYeP(t) ti LZ ,               (2) 
 
and thus undergoes a rotation within the binding site at the Larmor angular 
frequency ȦL = BoȖ/2, bounded by the complex-valued accumulation term Y(t): 
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where  
Į = ȕ + BoȖ ; 2
--=1,2
22 4ZDDO r .      
 
For the physically relevant case for which the infrared oscillator frequency is 
much greater than the Larmor frequency, _Į2_ << 4Ȧ2, so that tit ee Z
ZD
r
r o2
4 22
,  
[Edmonds, 1993; Muehsam et al., 1994, 1996], and, 
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Thus, the thermal component of the trajectory maintains the form of a coherent 
oscillator driven by thermal noise, )n(W , and the trajectory does not devolve into 
a random walk, as assumed by the model of the particle in a “box” [Adair, 2006]. 
Physically, this is clear, as oscillator restoring force must be much greater than the 
thermal noise spectral density in order for the particle to remain bound and 
undergo oscillations in the infrared region. 
 
From this, the ensemble average of the oscillator amplitude, was derived: 
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Note that neither the magnetic field strength nor the charge-mass ratio appears in 
equation (4). Thus, while the thermal term follows the Larmor trajectory, the time-
dependence of the magnetic field contribution to the thermal accumulation 
disappears for the physically realistic condition _Į2_ << 4Ȧ2, so that the magnetic 
field does not directly influence the amplitude of the thermal term. The thermal 
trajectory may then be evaluated from equations (2) and (4): 
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The thermal component P(t) of the motion thus follows the Larmor trajectory, 
rotating in the magnetic field at the Larmor frequency (Larmor frequency ȦL = 
BoȖ/2), bounded by an envelope determined by the ensemble average )(tP .  
 
Thus, thermal forces convey the oscillator amplitude towards its equilibrium 
value, while the trajectory rotates at the magnetic Larmor frequency, so that the 
magnetic field bioeffect itself is transduced by thermal noise. Because the thermal 
component P(t) itself undergoes Larmor precession, information regarding the 
magnetic field environment is in effect transduced by thermal forces, an idea first 
proposed by the late Alessandro Chiabrera [Chiabrera, et al., 1992] and further 
developed by Mikhail Zhadin [Zhadin, 1998]. In other words, the thermal 
component P(t) contains, in the form of coherent rotation of the oscillator 
orientation at the Larmor frequency, information regarding the local magnetic 
field. 
 
 
CORRESPONDENCE TO PREDICTIONS OF ION PARAMETRIC 
RESONANCE MODEL 
The above summary shows that the rate of angular rotation of the oscillator is 
independent of thermal forces and physical characteristics of the oscillator, such 
as the oscillator potential, initial position, initial velocity, etc. Thus, the thermal 
component follows the Larmor trajectory, regardless of the specific physical 
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characteristics of the oscillator, in accord with earlier results [Zhadin et al., 1998]. 
This suggests that it is possible to form a metric for biochemical reactivity that is 
independent of the MKS values of position and velocity and dependent wholly 
upon the Larmor frequency and bound lifetime [Muehsam et al., 2009b]. Here, a 
new metric [Muehsam et al., 2010] for the Lorentz force model is presented that 
exhibits close correspondence with the results of a meta-analysis of recent 
experiments [Binhi, 2007] and the Bessel function predictions of the ion 
parametric resonance (IPR) model [Blackman et al., 1995]. The variance of the 
projection of the oscillator angular displacement onto the Cartesian axis defined 
by the initial oscillator orientation measures the range of angles through which the 
oscillator passes: 
 
R(t) var cos ZL (t)dt
0
tb
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 where ȦL = BȖ/2 is the Larmor frequency, determined by resultant AC/DC 
magnetic field, and tb is the bound lifetime of the system, taken here for tb >> 
Larmor period of the DC field. Thus, R(t) provides a simple measure of the 
reactivity. The magnitude of the ELF effect is proportional to the variability in the 
angular excursions of the oscillator: greater variability corresponds to the 
oscillator occupying a wider range of orientations, thus increasing orientations 
occupied and the likelihood of meeting a preferred orientation. R(t) thus provides 
a means of computing reactivity for DC, AC, parallel and perpendicular AC/DC 
magnetic field combinations. 
  
The reactivity measure R(t) provides a geometric measure of the variability of 
oscillator orientations for combined AC/DC magnetic fields. Figure 1 shows that 
R(t) yields a characteristic landscape of reactivities for specific values of AC and 
DC frequencies and amplitudes, shown here for parallel AC/DC field combination 
for tb >> 10 Larmor periods . This landscape is an inherent geometrical property 
of the Larmor frequency itself, and not dependent upon specific characteristics 
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such as charge/mass ratios, damping coefficients, oscillator frequency. Reactivity 
is given as a function of AC/DC magnetic field amplitude and the ratio of the AC 
frequency to fL, to the Larmor frequency of the charged particle in the DC field. 
Note the prominent peaks occurring when the AC frequency is twice the Larmor 
frequency = cyclotron frequency. In the same manner as found previously, 
predictions depend upon bound lifetime (kinetics), and converge rapidly to the 
results shown in the figure for lifetimes longer than several DC Larmor periods. 
For such lifetimes, the effects of AC phase averaging are negligible, yielding a 
metric with no arbitrary parameters [Muehsam et al, 2009b]. Figure 2 shows a 
comparison of the predictions of R(t) with the Bessel function predictions of the 
IPR model and data from a metanalysis of seven independent experiments [Binhi, 
2007] reporting bioeffects for parallel AC/DC magnetic field combinations. The 
results show that R(t) provides a slightly better fit to the data than the IPR 
predictions, particularly in the region where the ratio of AC/DC amplitudes > 5 
(here, Binhi uses the magnetic field, H, rather than magnetic induction, B). 
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Figure 1: R(t) exhibits maxima and minima in desorption kinetics for bound ion, 
with prominent regions of enhanced reactivity at the cyclotron frequency and 
subharmonics, including the Larmor frequency. The reactivity R(t) is uniquely 
determined by the Larmor frequency, and thus reflects the intrinsic geometry the 
AC/DC magnetic field combination. This yields a model derived only from the 
Larmor frequency which employs no additional adjustable parameters to 
accommodate experimental data. 
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Figure 2:. Comparison of results of Lorentz model with Bessel function solution 
of ion parametric resonance (IPR) model and metanalysis of seven independent 
experiments yielding bioeffects in parallel AC/DC magnetic fields. The Lorentz 
force model fits the data at least as well as the Bessel function solution offered by 
the IPR model and provides a better fit for HAC/HDC > 5. Data shown from Binhi, 
2007. 
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Figure 3: Comparison of results of Lorentz model with Bessel function solution 
of ion parametric resonance (IPR) model in PC-12 neurite outgrowth model. 
Lorentz model employs a single Ca2+ ion target (dotted line), whereas IPR model 
requires linear superposition predictions for H+, Mg2+ and Li+ ions, each over 
specific frequency ranges, with arbitrary choice of best-fit coefficients for each 
Bessel function (solid line). Data compared to Blackman et al., 1995. 
 
 
HYDRATION AND ION BINDING 
Because all biochemical reactions occur within the aqueous subcellular matrix, any 
comprehensive model of EMF bioeffects must take into account the aqueous 
environment of the target. However, explicit treatment of role of water is presently 
lacking in models for EMF bioeffects. The dynamics of ion/water interactions play 
a critical role in ion binding, through the molecular recognition of hydrophobic 
patches by incoming ligands or drug molecules [Balasubramanian et al., 2003], 
and water structuring plays a key role in the determination of protein allostery 
 ͳͲʹ
[Royer, 1996]. Because the passage from interfacial free water to bound water is 
on the order of a few kT, in order to affect this passage, the magnetic field 
strength would have to be sufficient to alter bound lifetime, so that magnetic fields 
below the mT range cannot be expected to affecting this passage directly, as 
mentioned previously. However, rotational fluctuations within the degrees of 
freedom available to bound ions are on the order of 0.4 kcal/mole, or just slightly 
less than kT [Lazaridis et al., 2002]. These rotational fluctuations in potential 
energy must be distinguished from changes in potential energy due to orientation 
changes that occur as a direct result of changes in ionic distance to hydration. 
Such changes in energy are greater than kT differ for different ions [Vaslow, 
1963; Hyun et al., 1995], and thus could not be induced by LPM. It is interesting 
to note that changes in energy of hydration due to rotational and translational 
displacements differ for different ions, resulting in an energetic signature that 
contributes to the selectivity of ion channels [Laio and Torre, 1999]. 
 
In the absence of the magnetic field, the hydration angle between the ion and the 
net dipole moment of the environment assumes a distribution of available values, 
cosș, with an associated probability of occurrence P(cosș), as shown in figure 4. 
The specific form of P(cosș) is dependent upon the type of ion and the solvent 
[Rashin et al., 1994]. 
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Figure 4. Left: Probability of cosș  for the first shell of waters around a chloride 
ion in the aqueous environment. The angle ș represents the angle between the 
ionic oscillator and the net dipole moment of the aqueous environment. From 
[Hyun et al., 1995]. Right: Relative probabilities of different orientations of water 
molecule near an inert gas molecule, Ne. The angle ș represents Ne-O-H angle. 
Data from [Rashin et al., 1994]. 
 
The interaction energy between an ion and its aqueous environment may be 
described energetically via the angle of hydration between the ion and dipole 
moments in its vicinity. The principle of superposition allows for the reduction of 
the interaction with the ion of all waters to that of a single resultant dipole 
moment, embedded in a continuous medium of known dielectric constant. This is 
known as the reduced point dipole [Hyun et al., 1995], and allows for the 
definition of a potential energy function for the ion/water system. Thus, change in 
hydration energy may be taken to first order [Vaslow, 1963; Khalili et al., 2004], 
so the energy required to orient, e.g. rotate through an angle ș, the relative angle 
between the dipole field and the ion follows the familiar form: 
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Where the E(r) is the effective electric field felt by the dipole at a distance r from 
the ion, e.g. the effective dipole electric field due to charges of hydration [Laio et 
al., 1999]. In the binding site, E(r) is given by the distance between the ion and 
reduced dipole of the system, a constant for the duration of the bound lifetime 
[Podgornik et al., 1987; Paul et. al, 2001 ; Teschke et al., 2001] so that 
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where q is the ionic charge and the effective local dielectric constant is given İ(ro) 
is given by: 
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where maxH = 78 and minH = 2.63, and Ȝ =1 Angstrom [Podgornik et al., 1987; Paul 
et. al, 2001 ; Teschke et al., 2001], and ro is the distance between the Outer and 
Inner Helmholtz Planes (IHP) at the protein surface [Kalinin, et al., 1996]. 
 
Thus, the contribution 'GT  to the change in free energy due to orientation to 
mean energy of the ion in the dipole field may be written as a function of 
)(cos( tT : 
 
'GT (t,T )  U(t,T )   PE(ro)cos(T(t))  PE(ro) cos(T(t) .  (11) 
 
In the absence of the magnetic field, to first order in E(r), the mean value of 
cos(ș), has been shown to assume a constant value [Booth, 1951; Hyun, et al., 
1995]: 
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cos(T(t)  PE(r ) / 3kT  const.     (12) 
 
Thus, a constant-value baseline exists, for comparison with changes in )(cos( tT  
due to rotation at the Larmor frequency in order to provide a meaningful measure 
of the magnetic field induced change in reactivity. Figure 4 shows a typical free 
energy landscape, from Equation 11, for a parallel AC/DC magnetic field 
combination where )(cos( tT  is computed over 1 period of the DC magnetic field 
Larmor frequency and phase averaged in the manner described in Muehsam et al., 
2009b. Note the prominent resonance occurring at the Larmor frequency when 
AC/DC amplitude are approximately equal, which is an inherent property of the 
Larmor frequency for a parallel AC/DC field combination. 
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Figure 5. Free energy ǻGș for parallel AC/DC magnetic field combination, with 
DC = 20 ȝT, employing charge/mass ratio for calcium, in normalized units. 
Bound lifetime taken here = 1 Larmor period of DC magnetic field, no phase 
averaging employed. Note that free energy landscape is and inherent property of 
the Larmor frequency, and thus may be expressed solely in terms of AC/DC 
magnetic field amplitudes and frequency. 
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LARMOR ROTATION OF WATERS OF HYDRATION AT PROTEIN 
SURFACE 
The dynamics of ion/water interactions play a critical role in ion binding, through 
the molecular recognition of hydrophobic patches by incoming ligands or drug 
molecules [Balasubramanian et al., 2003] and in the allosteric regulation of 
protein function in macromolecules such as hemoglobin [Royer, 1996]. Because 
the passage from interfacial free water to protein bound water is on the order of a 
few kT, protein hydration forms long-lived or semi-permanent hydration layers, 
and a weak (< 100 ȝT) magnetic field cannot be expected to affect this passage 
directly. However, the rotational degrees of freedom of bound waters described 
above (see Figure 4) offer a means by which ELF magnetic field effects could 
occur. Here, we analyze in spherical coordinates the effect of the magnetic field 
on a water molecule bound to a charged interface, subject to an initial thermal 
motion in the ș-direction, and free to rotate in ĳ-direction [Rashin et al., 1994; 
Hyun et al., 1995]. The water molecule is thus modeled as a rigid, charged linkage 
bound to a surface for a lifetime >> the Larmor period of the magnetic field. 
Given an initial, thermally activated velocity in the ș – direction, 
 
xo
 TTrv ,     (13) 
 
and a magnetic field up along the z-axis, static or varying slowly relative to the 
thermal noise [Edmonds, 1993], 
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the Lorentz force is thus in the ĳ-direction: 
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In general, the ĳ-component of the acceleration is given by 
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but, for the constrained system of a water molecule bound to a charged interface, 
dr/dt = 0 so that,  
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From equations (16) and (18) 
 
TTTITTI coscos2sin
xxxxx
  r
m
qBrr o     (18) 
 
so that, for small excursions of ș, 
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Thus, the application of the magnetic field results in a rotation at the Larmor 
frequency in the ĳ-direction. For charged species such a bound water molecules or 
charged ligands that may be modeled as a constrained linkage, this suggests that 
the introduction of the magnetic field also introduces a component into the motion 
that undergoes rotation at the Larmor frequency.  
 
DISCUSSION AND CONCLUSIONS 
Future theoretical models for biological EMF transduction will require an explicit 
treatment of the role of water, which to date has not occurred. As all biological 
interactions occur within a aqueous medium, any successful attempt at describing 
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EMF bioeffects must account for interactions with hydration layers around ions, 
proteins, and ligands. Here, using a reasonable approximation of a water molecule 
as a linkage bound to a surface, it is shown that the magnetic field may cause 
rotation at the Larmor frequency in waters of hydration that are tightly bound at a 
protein aqueous interface. The results may be interpreted from the point of view of 
reaction kinetics and changes in the electrochemical properties of the aqueous 
interface at the IHP. Using [L] to represent the concentration of a ligand such as 
an ion, [R] to represent the receptor molecule or protein surface concentration, the 
final change reaction in rate constant kb can be written as a function of the 
electrostatic potential Ȍ at the IHP [Kalinin et al.,1996]: 
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[L][R]
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where [L·R] is the concentration of the bound complex, į is the fraction of 
available sites filled, ȡ is called the tail lateral interaction parameter (negative for 
attractive interactions), e is the electron charge. 
 
Since the Gibbs free energy defines the final change in reaction rate: 
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combining equations (20) and (21), rotation at the Larmor frequency resulting in a 
change in 'GT  may thus be interpreted as a change in effective electrostatic 
potential at the IHP: 
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It has been suggested previously that modulation via Larmor precession of 
ion/water orientation angles could modulate thermal fluctuations in the 
instantaneous local dielectric constant İ(t) at the binding site and thus the kinetics 
of binding processes at the Helmholtz planes at electrified interfaces may be [Pilla 
et al., 1997]. Because a change in free energy ǻGo can also be interpreted as a 
change in local effective dielectric constant, rotation at the Larmor frequency may 
be interpreted as inducing such a change:  
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where Eo is the electrostatic interaction energy in the absence of the magnetic 
field. Physically, as <cos(ș)> increases, the ion/dipole angle decreases towards 0 
(or 180º), thus increasing the (negative) potential energy of the system. From this, 
the local effective dielectric constant is given by: 
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Thus, increased variability in the motion due to rotation at the Larmor frequency 
results in a reduction of the local effective dielectric constant, providing a physical 
interpretation of the change in binding kinetics due to the magnetic field.  
 
The Lorentz model offers an explanation, and theoretical basis for weak ELF 
magnetic field effects, based upon the classical dynamics of the bound charged 
oscillator. Information regarding the AC/DC magnetic field configuration is 
transferred via the Larmor frequency into the thermal motion of the oscillator. A 
physically meaningful geometric measure of the dynamics of ion motion predicts 
resonances in the reactivity of a bound ions or waters of hydration due to weak 
AC and AC/DC magnetic fields. The underlying mathematics is a straightforward 
analysis of the classical dynamics of a bound particle in the magnetic field, 
 ͳͳͳ
subject to thermal noise forces. Here, a new metric based upon the variability of 
the oscillator position is shown to yield predictions in close agreement with those 
of the IPR model. The results suggest that desorption kinetics can be significantly 
accelerated or slowed in a manner dependent upon the ratio of AC/DC field 
strengths. The model also provides a physically reasonable mechanistic 
explanation for observed ELF effects including the large body of observed weak 
50/60 Hz magnetic field bioeffects. Comparison with experiments shows that, the 
Lorentz model predicts experimental results equally well as the IPR model, and 
requires only a single-ion charge-mass ratio. In contrast, in order to fit available 
data, the IPR model requires of multiple ion superpositions over specific 
frequency ranges or and the use of linear combinations of Bessel functions with 
arbitrary coefficients, as used in Blackman et al., 1995 and Binhi, 2007. Perhaps 
more importantly, the IPR model neglects thermal noise forces, whereas the 
Lorentz model accounts for these forces and shows that, rather than presenting an 
obstacle to detection, thermal noise may play an essential role in ELF magnetic 
field transduction. Thus, the inclusion of thermal noise forces, and the much 
smaller number of assumptions and variable parameters suggest that Lorentz force 
model to be a more parsimonious description of the transduction mechanism for 
weak AC and DC magnetic field bioeffects.  
 
The necessity of a model for EMF effects that accounts for interactions with the 
aqueous medium is clear. In addition, there exists a substantial and diverse body 
of reports of EMF-induced changes in the physicochemical properties of water 
and aqueous solutions, suggesting that EMFs do in fact act directly on the aqueous 
medium. Extensive research which is likely to have significance to biology has 
been conducted in physical chemistry and the colloid sciences for more than 
twenty years. Magnetic treatment of water is now commonly employed to inhibit 
scaling in industrial heat exchangers and pipes [Busch et al., 1986; Yoon et al., 
1994; Koshoridze et al., 2009; Stuyven et al., 2009]. Electric and magnetic field 
effects have been observed for water surface tension [Amiri et al., 2006], diffusion 
of ions in solution [Guo et al., 2011], hydrogen bonding structure [Cai et al., 
 ͳͳʹ
2009], precipitation of barium oxalate [Berton et al., 1993], CaCO3 and CaSO4 
[Beruto et al., 1993; Alimi et al., 2006], electrolytic potential [Otsuka et al., 2006], 
electrical conductivity [Akopian et al., 2005], evaporation rate [Guo et al., 2012], 
nucleation and crystal growth rates of diamagnetic inorganic salts [Lundager 
Madsen, 1995] and suspension stability [Higashitani et al., 1992]. In addition, and 
perhaps of relevance to our observations of long-lasting EMF effects on human 
hemoglobin [Muehsam et al., 2013], a variety of EMF effects on aqueous 
solutions have been observed to persist for up to several days after the removal of 
applied EMFs. For example, changes in zeta potential and diffusivity of 
nonmagnetic colloids [Higashitani et al., 1990, 1992], zeta potential of TiO2 and 
CaCO3 [Chibowski et. al., 1990, 1994; Holysz, et al., 2002], surface free energy of 
CaCO3 [Chibowski et al., 1994; Holysz, et al., 1994], Al2O3 [Lubomska et al., 
2001] and in the nucleation frequency of CaCO3 [Higashitani, K. et. al., 1993]. 
Changes in UV and IR spectra of water due to exposure to static magnetic fields 
have also been reported [Usatenko et al., 1977; Fesenko et al., 1995]. Magnetic 
pretreatment of water has been reported to enhance the yields of plants, livestock 
and paramecium [Lin et al., 1990], alter cell density, size and nuclear diameter in 
catfish hepatocytes [Garg et. Al, 1995] and affect the estrus cycles of mice 
[Pandey et. al., 1996], suggesting that physicochemical changes in the aqueous 
solutions themselves may be the mediators of some EMF bioeffects.  
 
The above reports of EMF effects directly on aqueous solutions suggests that 
these physicochemical changes themselves may be relevant to biological EMF 
transduction. Given the present state of knowledge, a more comprehensive 
theoretical picture of water and aqueous solutions is needed in order to clearly 
explain EMF effects on water structure. However, some reasonable speculation 
has been made regarding magnetic field induced changes in water conformational 
structure [Susak et al., 2005], and how these may alter biological activity [Rai et 
al., 1995; Rai, 1997]. Observations of EMF effects on water hydrogen bonding 
structure [Inaba et al., 2004; Cai et al., 2009] are in accord with molecular 
dynamics modelling [Chang et al., 2006]. Because hydrogen bonded water 
 ͳͳ͵
structures are essential factors governing the internal motions of protein molecules 
[Chou, 1985; Royer et al., 1996], application of the Lorentz model to waters of 
hydration may suggest a general mechanism for weak ELF magnetic field 
detection in proteins, and a possible explanation of observed magnetic field 
effects on human hemoglobin [Muehsam et al., 2013; Mousavy et al., 2009; 
Magazù et al., 2010; Tao et al., 2011; Sosa et al., 2005; Shalaby et al., 2006; 
Sakhnini et al., 2001; Iwasaka et al., 2001; Milweski et al., 2006]. 
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b. MAGNETIC FIELD EFFECTS ON NEURONAL SPIKE TIMING 
 
INTRODUCTION 
A variety of electric field effects on neuronal systems have been reported, for 
applied subthreshold electric field strengths too weak to directly induce action 
potential firing, including time-dependent modulation of neuronal excitability 
[Bikson et al., 2004], sensitivity to sub-mV/mm electrical fields in rat 
hippocampal slices [Francis et al, 2003], increase in Ca2+-activated K+ channel 
mean open time in isolated dorsal root ganglia [Marchionni et al., 2006], enhanced 
expression of voltage-gated Ca2+ channels [Grassi et al., 2004], effects on 
membrane potentials and spike timing [Deans et al., 2007; Radman et al, 2007], 
gating of ion channels [Kolomytkin et al., 2007], changes in neuronal timing and 
rate [Reato et al., 2010], neuronal firing and epileptiform activity [Bikson et al., 
2004]. Bioeffects due to static (DC) and ELF exposures, for which the induced 
electric field is negligible, include changes in EEG activity dependent up temporal 
sequencing of magnetic pulses [Cook et al., 2009], biphasic response in 
epileptiform spike activity in epileptic patients [Dobson et al., 2000], modulation 
of inactivation kinetics in K+ channel currents in trigeminal root ganglion neurons 
[Shen et al., 2007], changes in action potential shape and spike timing 
[Wieraszko, 2000; Vargas  et al, 2006; Ahmed et al., 2008], modulation of Ca2+-
dependent K+ channel behavior [Azanza et al., 1988; Azanza, 1990], inhibition of 
neurite outgrowth and reversal of inhibition of Ca2+ efflux in PC-12 cells induced 
by CGS21680, a selective adenosine A2A receptor agonist [Wang et al., 2010], 
neurite outgrowth [Blackman et al., 1985, 1995; Morgado-Valle et al., 1998], 
decrease in acetylcholinesterase activity in cerebellum synaptosomal membranes 
[Ravera et al, 2010], spike timing in cortical neurons [Modolo et al., 2010], spike 
timing in neuronal ganglia in bees [Schiff, 1991], and modulation of 
hyperpolarizing K+ channels [Tonini et al., 2001], resting EEG in human subjects 
[Cook et al., 2004], neural processing of acute pain [Robertson et al., 2010]. 
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DC MAGNETIC FIELD EFFECTS ON SPIKE TIMING  
While the biophysical basis for neuronal electric field effects may be understood 
by the superposition of the applied electric field with the membrane potential of 
single cells or cell arrays [Muehsam et al., 1999; Apollonio et al., 2000; Wang et 
al., 2009], the mechanisms for magnetic field effects remain unclear. Here, in light 
of experimental observations of magnetic field effects on action potential shape 
and neuronal spike timing [Azanza et al., 1988; Azanza, 1990; Schiff, 1991; 
Trabulsi et al., 1996; Wieraszko, 2000; Ahmed et al., 2008; Tonini et al., 2001; 
Modolo et al., 2010; Vargas et al., 2006], a model is proposed for EMF magnetic 
field effects on Ca2+-dependent K+ channel behavior. Previous models for electric 
field effects have been offered, based upon Hodgkin-Huxley (HH)-type 
membrane models [Xia et al., 1998; Apollonia et al., 2000]. An HH-type model 
adapted to an Izhikevich neuronal model [Izhikevich, 2004] for GSM mobile 
phone exposures has been suggested [Minelli et al., 2007], also predicting changes 
in spike timing due to EMF exposure, and another HH model predicts periodic 
and chaotic dynamics in response to sinusoidal electric field stimulation [Jiang et 
al., 2009]. A model for microwave frequency electric field effects on a simplified 
ion channel model has also been offered [Cagni et al., 2007]. Regarding magnetic 
field effects, a model employing an Izhikevich neuron treated only the electric 
field induced by a time-varying magnetic field [Modolo et al., 2010]. A Zeeman-
Stark model for weak magnetic field effects has been suggested [Bruna et al., 
2001], however this model does not account for the presence of thermal noise 
forces [Bianco et al., 1992]. Also, although the computational simplification 
achieved by the Izhikevich approximation is desirable, this simplicity comes at the 
cost of the ability to quantitatively assess changes in biophysical quantities such 
as channel conductance, time constants, etc. My previous analyses showed that 
the sensitivity to exogenous EMF of an array of cells with HH-type membranes in 
gap junction contact is dependent upon the membrane resting potential [Muehsam 
et al., 1999]. Thus, the model considered here employs an HH-type model to 
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evaluate the effects ELF magnetic field modulation of Ca2+ activity via the 
Lorentz model on K+ channel currents and spike timing. 
 
Reports that the magnetic field can act on neuronal cells through Ca2+-dependent 
pathways include increased Ca2+ flux in PC-12 cells [Wang et al., 2010], magnetic 
field–induced fluctuations in intracellular Ca2+ concentration which modulate 
action potential shape and neuronal spike timing [Trabulsi et al., 1996] 
(dantrolene, an inhibitor of intracellular Ca2+ channels, inhibited these magnetic 
field effects [Wieraszko, 2000]), EMF modulation of spike timing occurring 
through changes in intracellular Ca2+ concentration which were blocked using 
nifedipine to block Ca2+ channels and apamin to block Ca2+-activated K+ channels 
[Tonini et al., 2001], direct modulation of Ca2+-activated K+ channel activity 
[Marchionni et al., 2006], and of voltage-gated Ca2+ channels [Grassi et al., 2004]. 
Thus, here we consider a small-conductance Ca2+-dependent K+-current IK as a 
function of the effective free internal Ca2+ concentration and membrane voltage V 
[Engel et al, 1999; Purvis et al., 2005; Wang et al., 2011]: 
 
I K Ca
2ª¬ º¼eff   g_ K zK Ca2ª¬ º¼eff  V VK    (1) 
 
where and g
_
K = 37 mmho/cm
2; VK = 12 mV, and all other parameters governing to 
K+, Na+, and leak conductance relations are given according to [Hodgkin et al., 
1952a, 1952b; Fishman et al., 1977; Purvis et al., 2005]. The modulation zK  of the 
Ca2+-dependent conductance is given by [Engel et al, 1999] 
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where zo is an arbitrary constant. Ca
2+ gating of SK channels is mediated by 
binding of Ca2+ to calmodulin (CaM) and subsequent conformational alterations 
in the channel protein alpha sub-units [Xia et al., 1998; Keen et al., 1999]. Thus, 
the effect of the magnetic field effect may represented as a modulation of the 
effective free Ca2+ concentration [Muehsam et al., 1996, Muehsam et al, 2009a, 
2009b], which considered in detail the effect of the magnetic field on Ca2+/CaM 
binding. For a static magnetic field Bo, the simplest measure of reactivity is that 
the effective Ca2+ concentration is proportional to the Larmor frequency 
[Muehsam et al., 1996; Pilla et al., 1997]. For this measure, for example, an 
increase in the Larmor frequency increases the angular area per unit time spanned 
by the oscillator, resulting in an increase in effective free [Ca2+], so that  
 
Ca2ª¬ º¼eff  Jo*B,      (5) 
 
where Jo is an arbitrary constant by magnitude of observed bioeffects in a given 
magnetic field B and *  is the target gyromagnetic ratio. For a given choice of Jo , 
changes in ELF exposures from baseline may then be assessed. It is important to 
note that the Lorentz model predicts a change in effective Ca2+ concentration, 
interpreted in terms of the change in reaction kinetics, due to increased availability 
of Ca2+ for binding to CaM, rather than an increase due to direct magnetic field 
effects on ionic currents through the membrane [Muehsam et al., 1996]. 
 
The H-H model considered here may be solved via numerical integration using a 
Runge-Kutta method, and for the conditions employed here the results are stable 
over changes in step size [Moore et al., 1974; Engel et al, 1999; Stewart et al., 
2009]. Matlab code is shown in the Appendix. Adjusting Jo to yield several 
mmho/cm2 sensitivity in the K+ conductance g
_
K zK  in the PT range, in order to 
simulate the effects reported by [Tonini et al., 2001; Marchionni et al., 2006], 
Figure 1 shows the effect of a static magnetic field on single spike shape. The 
 ͳ͵Ͳ
spiking behavior is is induced here by -10 mV constant current stimulus beginning 
at t = 10 ms and continuing throughout the simulation. Increasing magnetic field 
from 25 PT to 250 PT delays spike onset and hastens the return to interspike 
baseline, thus delaying action potential initiation [Engel et al., 1999]. Because 
many experiments are carried out in the ambient geomagnetic field, Figure 2 
shows action potential response to a 200 PT DC field applied parallel to the 50 PT 
ambient field, i.e. 250 PT total field strength. Integrating over a 250 ms interval, 
with a  -10 mV constant-voltage stimulus applied from t = 10 ms and continuing 
throughout the simulation, and, in the absence of applied magnetic fields, i.e. 50 
PT geomagnetic field exposure only, the model yields a train of action potential 
spikes with mean interspike interval (I-I) = 11.9 ms during stimulus, as shown in 
Figure 2. Addition of a 200 PT DC field increases the I-I to 14.0 ms, as shown in 
Figure 2, right hand plot. Computing across the range of magnetic field 
amplitudes from 0-250 PT results in a monotonically increasing mean I-I with 
increasing magnetic field strength (Figure 3). Carrying the computation out to 500 
PT shows that the I-I remains nearly constant with increasing magnetic field after 
approximately 350 PT, approaching asymptotically a value of I-I = 14.4 ms (data 
not shown). The results above are in accord with observations that an ELF PT-
range magnetic field increased the mean open time of a Ca2+-dependent K+ 
channel [Marchionni et al., 2006]. 
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Figure 1: Effect of static magnetic field on spike timing, determined by numerical 
integration of H-H type model using Runge-Kutta method. Spiking behavior is 
induced by -10 mV constant current stimulus beginning at t = 10 ms and 
continuing throughout the simulation. Increasing magnetic field from 25 PT to 
250 PT delays spike onset. 
 
 
 
     
 
 
 
 ͳ͵ʹ
 
 
Figure 2: Action potential spike trains in 50 PT ambient geomagnetic field and 
with added 200 PT static magnetic field. Stimulus commences at t = 10 ms and 
continues throughout the simulation, producing a regular train of action potential 
spikes. In ambient field only, mean interspike interval (I-I) = 11.9 ms. Addition of 
200 PT static magnetic field oriented parallel to 50 PT geomagnetic field 
produces train of action potential spikes with mean I-I = 14.4 ms.  
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Figure 3: Interspike interval computed across a range of applied magnetic field 
amplitudes from 0-250 PT, in parallel to 50 PT ambient geomagnetic field. 
Results show that increasing magnetic field strength reduces the neuronal firing 
rate. For field strengths from 350-500 PT, I-I remains nearly constant, converging 
asymptotically to I-I | 14.6 ms at 500 PT (data not shown). 
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AC AND AC/GEOMAGNETIC COMBINED EXPOSURES 
Because the magnetic field acts through modulation of the K+ conductance, time-
varying (AC) magnetic fields will result in a time-dependent modulation of 
neuronal behavior with. For clarity, the examples shown below are in the absence 
of the DC geomagnetic component. The effect, via equation 5, of a 200 PT AC 
magnetic field varying sinusoidally at 50 Hz is shown in Figure 3. The top plot is 
the AC field amplitude, and the bottom shows the resulting neuronal firing. Here, 
action potentials were triggered using a constant-voltage -10 mV stimulus 
beginning at t = 0 ms and continuing throughout the simulation, resulting in a 
uniformly spaced spike train with mean I-I = 13.6 ms. In contrast, because the 
precise spike timing is a function of both the baseline I-I and the rate of change of 
zK  with time, more complex behaviors may be found using various AC 
frequencies. For example, Figure 4, top plot, shows that for a 5 Hz 200 PT AC 
sinusoidal magnetic field, the time-dependent K+ conductance g
_
K zK  varies a 
twice the AC frequency, due to signal rectification by Equation 2. Thus, the 
pattern of spikes also repeats at twice the AC frequency, producing a train of 
action potentials with uneven spike timing. Increased I-I duration occurs while the 
magnetic field approaches the max/min of the AC cycle as shown in Figure 4, left, 
bottom plot. These results illustrate a real-time dependence of the spike timing of 
a Ca2+-dependent K+ channel. Superposition of parallel 5 Hz 200 PT AC filed 
with the 50 PT DC geomagnetic field yields the time-varying K+ conductance 
g
_
K zK (see Eqn 1) with periodic maxima every 100 ms shown in Figure 4, right, 
top plot. Here, the conductance and thus spike patterning repeats at the AC 
frequency. Figure 4, right, bottom plot, shows the change in spike patterning due 
to the introduction of the DC geomagnetic field. Note that fewer increases in I-I 
occur with introduction of geomagnetic field, due to decreased K+ conductance in 
times for which the AC and DC fields cancel significantly. For example, 
comparing Figure 4 left and right hand plots, adding the geomagnetic field results 
in significant cancellation for t = 50 – 150 ms, resulting in reduced conductance 
and thus and smaller values of I-I during this time period. 
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Figure 4: Left: Effect of AC magnetic fields on neuronal spike timing, in absence 
of geomagnetic field. Left: 5 Hz AC magnetic field yields time-varying K+ 
conductance g
_
K zK (top plot)  repeating at frequency = 2 X AC frequency, due to 
signal rectification by Eqn 2. 5 Hz AC field yields a train of action potentials with 
uneven spike timing (bottom plot), also repeating at 2X AC frequency. 
Amplitudes employed here = 50-200 PT, using parameters employed above. 
However, results apply to arbitrary nonthermal amplitudes, due to choice of Jo in 
Equation 5. Right: Addition of 50 PT ambient geomagnetic field to 5 Hz 200 PT 
AC magnetic field. Superposition of magnetic fields yields complex time-varying 
K+ conductance g
_
K zK with periodic maxima at AC frequency (top plot). Increase 
in interspike interval occurs during rising phase of change in conductance 
(bottom). Results suggest role of geomagnetic field in PT-range bioeffects.  
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DISCUSSION AND CONCLUSIONS 
An H-H type membrane model, when applied to a small-conductance Ca2+-
dependent K+-current channel, predicts an inverse relationship between Ca+2 
availability and the frequency of action potential firing [Engel et al, 1999; Purvis 
et al., 2005; Wang et al., 2011]. Application of the Lorentz model for magnetic 
field bioeffects [Chiabrera et al., 1992; Edmonds, 1993; Zhadin, 1998; Muehsam 
et al., 1994, 1996, 2009a, 2009b, 2010; Pilla et al. 1997] yields an increase in Ca2+ 
availability, thus increasing the I-I in a neuron undergoing continuous action 
potential spiking. To my knowledge, this is the first model presented which offers 
a magnetic field mechanism for effects on spike timing with a distinct molecular 
target. It is important to note that in this model, the magnetic field does not act 
directly upon the K+ current itself, the Ca2+ channel currents or the membrane 
potential itself. Rather, the action of the magnetic field is to modulate Ca+2/CaM 
activity, thus affecting the conformational states of the K+ channel protein [Xia et 
al., 1998; Keen et al;, 1999]. This causes a real-time change in K+ conductance, 
resulting in changes in spike train timing. Here, the model is applied to PT-range 
fields, and the results are in accord with previous observations of PT-range effects 
on spike timing and action potential shape [Tonini et al., 2001; Marchionni et al., 
2006; Wang et al., 2011]. The amplitude sensitivity of the model depends on the 
choice of the fitting parameter Jo . Thus, the results shown here may be applied 
across a wide range of nonthermal magnetic field amplitudes, including 
observations of mT-range effects [Azanza et al., 1988; Azanza, 1990; Trabulsi et 
al., 1996; Wieraszko, 2000; Ahmed et al., 2008; Modolo et al., 2010; Ravera et 
al., 2010]. Further research is required to determine the value of the fitting 
parameter, and requires experiments wherein spike timing is measured over a 
range of magnetic field amplitudes. At present, in the absence of more 
information allowing the value of Jo to be found empirically, the model only 
provides information comparing changes from baseline response due to different 
applied EMFs, rather than providing predictive results for a single magnetic field 
value. Despite this limitation, H-H models remain useful as they accept direct 
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input of physiological parameters such as membrane resistance, ionic 
conductance, time constants for channel behaviors, etc. [Xia et al., 1998; 
Muehsam et al., 1999; Apollonia et al., 2000; Cagni et al., 2007; Jiang et al., 
2009], and thus retain an advantage over the more computationally convenient 
Izhikevich-type approximations [Izhikevich, 2004; Minelli et al., 2007; Modolo et 
al., 2010]. 
 
Cognitive and physiological neurological effects due to a wide range of 
subthreshold EMFs have been shown to occur [Cook et al., 2002; 2006] and it is 
now well-established that many neurons exhibit membrane-potential responses 
such as changes in spike clustering and timing to subthreshold stimuli [Engel et 
al., 2008], providing further rationale for understanding bioeffects due to 
subthreshold EMFs. The spiking neuron model presented here exhibits a real-time 
sensitivity to changes in magnetic field amplitude. This suggests that bioeffective 
AC magnetic field frequencies themselves depend upon temporal neuronal 
activity, rather than being determined only by membrane/channel biophysical 
properties. Exposure to combined AC and DC fields alters spiking behavior in a 
time-varying manner, suggesting that signals could be developed to elicit specific 
changes in spike timing/patterning. The model thus provides a mechanism for 
understanding and perhaps manipulating neuronal activity using subthreshold ELF 
signals, and may help to explain observations that specific combinations and 
temporal sequences of subthreshold EMFs can alter neurological activity [Tsang 
et al., 2004; Ross et al., 2008; Cook et al., 2009]. Also, for a system with PT-
range sensitivity, the addition or removal of the ambient geomagnetic field 
significantly alters spike timing in a manner dependent upon the AC amplitude 
and frequency, perhaps supporting observations of neurological bioeffects due to 
variation with geography, shielding, or removal from the Earth’s magnetic field 
[Schiff et al., 1991; Del Seppia et al., 2000; Choleris et al., 2002; Zhang et al, 
2004; Prato et al., 2005; Vargas et al., 2006]. The Lorentz model suggests several 
metrics for reactivity, based upon ionic targets and effects on hydration layers of 
proteins and binding sites. All of these metrics are functions of the target Larmor 
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frequency in the applied magnetic field [Muehsam et al., 2009b, 2010]. 
Interestingly, for ambient-range magnetic fields, the Larmor frequencies for 
common ions and oscillating water molecules lie in the same ELF range as the 
EEG spectrum [Pilla et al., 1997], suggesting that these frequencies might couple 
directly with neural activity. 
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APPENDIX: MATLAB CODE FOR MAGNETIC FIELD EFFECT ON H-H 
SPIKING NEURON MODEL 
 
function HHspikes() % Adapted from HHSimplet.m Summer of Spikes 
%Summer Semester, 2009, elec4001 and engg7301, School of Information 
%Technology and Electrical Engineering, The University of Queensland, 
%Brisbane QLD 4072, Australia. 
 
% HH values 
g_K = 37;  
g_Na = 120; 
g_leak = 0.3; 
C_m = 1; 
V_K = 12;        % not -12 (H-H original paper has error in it) 
V_Na = -115;      
V_leak = -10.6;  
 
sim_time = 300;% total simulation time in milliseconds 
t_step = 0.01;           % timestep in milliseconds 
N = 1 + sim_time/t_step; % total number of timesteps 
numb = N; 
 
V = zeros(1,N); n = zeros(1,N); m = zeros(1,N); h = zeros(1,N); 
 
V_rest = 0; 
V(1) = V_rest; 
n(1) = alpha_n(V_rest)/(alpha_n(V_rest)+beta_n(V_rest)); 
m(1) = alpha_m(V_rest)/(alpha_m(V_rest)+beta_m(V_rest)); 
h(1) = alpha_h(V_rest)/(alpha_h(V_rest)+beta_h(V_rest)); 
 
time = 0:t_step:sim_time;   % time 
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% input current 
Iext = zeros(1,N); 
Iext(round(10/t_step):round(990/t_step)) = -10; 
 
% adding variable magnetic field quantities 
Btot = ones(1,numb); Bfactor  = zeros(1,numb); g_KtimeVar = zeros(1,numb); 
Bo = 50e-6*ones(1,numb); %50e-6; %ambient geomagnetic field 
B = 100e-6*ones(1,numb); %50e-6*sin(2*pi*50*1e3*time); %applied magnetic 
field 
Bac = B.*cos(2*pi*5*1e-3*time); Btot = Bo + Bac; Bfactor = Btot; %./Bo; %For 
low fields, this is the ratio of total Larmor frequency relative to that of ambient 
geomagnetic field.  
charge=3.2*10^(-19);mass=7*10^(-26);gamma=charge/(2*mass); wLo = 
.5*gamma*Bo; fLo = wLo/(2*pi); wL = .5*gamma*B; fL = wL/(2*pi);%; 
tlarm=(4*pi*mass)/(B*charge); %tmax = period of Larmor frequency of DC field 
 
Caconc = 1e6*0.0025*Bfactor; % correct for uT 1e6 
Caconc = 0.004*Caconc./max(Caconc);%-2.7e-3; % Engel 
%z_K = (1./(1+(0.0025./Caconc).^2)); %Purvis  
%z_K = 1.0; % For testing purposes 
z_K = ((Caconc./0.0025).^2)./((1+(Caconc./0.0025).^2));% Engel 
 
g_KtimeVar = g_K*z_K;  
%g_KtimeVar = 37*((g_KtimeVar)./max(g_KtimeVar)); 
%g_KtimeVar = 37*((g_KtimeVar+17)./max(g_KtimeVar+17)); 
%g_Ktime = g_K 
max(g_KtimeVar); g_KtimeVar = g_K*z_K+(37-max(g_KtimeVar));  
 
subplot(2,1,1), plot(time,g_KtimeVar); %g_KtimeVar) 
set(gca,'ylabel',text(0,0,'gK * zK')) 
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set(gca,'xlabel',text(0,-2,'Time (ms)')) 
 
% numerical integration 
tic; 
for i = 2:N 
     
    %I_K = g_K*n(i-1)^4*(V(i-1)-V_K); %original, time-constant V_K 
    %I_K = g_Ktime*n(i-1)^4*(V(i-1)-V_K); %adding variable g_K 
    I_K=g_KtimeVar(1,i)*n(i-1)^4*(V(i-1)-V_K);%time-dependent g_K 
    %I_K = g_K*n(i-1)^4*(V(i-1)-V_Ktime(i)); % time-dependent V_K 
    I_Na = g_Na*m(i-1)^3*h(i-1)*(V(i-1)-V_Na); 
    I_leak = g_leak*(V(i-1)-V_leak); 
     
    deriv = (Iext(i) - (I_K + I_Na + I_leak))/C_m; 
    V(i) = V(i-1) + deriv*t_step; 
    
    m_deriv = alpha_m(V(i))*(1-m(i-1)) - beta_m(V(i))*m(i-1); 
    m(i) = m(i-1) + m_deriv*t_step; 
    n_deriv = alpha_n(V(i))*(1-n(i-1)) - beta_n(V(i))*n(i-1); 
    n(i) = n(i-1) + n_deriv*t_step; 
    h_deriv = alpha_h(V(i))*(1-h(i-1)) - beta_h(V(i))*h(i-1); 
    h(i) = h(i-1) + h_deriv*t_step; 
 
%computing interspike interval 
%timej = zeros(1,N); 
%tempvar = 0; 
%for j = 2:N 
 %   if -V(j) > 96 
  %      timej(1,j) = time(j)-tempvar; %-timej(1,j-1); 
   %     tempvar = time(j); 
    %    j = j + 100; 
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    %end 
%end 
%interval = max(timej) 
     
end 
toc; 
 
subplot(2,1,2), 
plot(time,-V) 
dis = [time' g_KtimeVar' -V']; 
save disdat250.dat dis /ascii 
  
hold on 
 
%plot(time,-Iext-22) 
%plot(time,g_Ktime,':') 
hold off 
 
set(gca,'ylabel',text(0,0,'Membrane Potential (mV)')) 
set(gca,'xlabel',text(0,-2,'Time (ms)')) 
%set(gca,'xlim',[9 17]) 
 
end 
 
%H-H voltage-dependent quantities here: 
function result = alpha_n(V) 
    result = 0.01*(V+10)/(exp((V+10)/10)-1); 
end 
 
function result = beta_n(V) 
    result = 0.125*exp(V/80); 
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end 
 
function result = alpha_m(V) 
    result = 0.1*(V+25)/(exp((V+25)/10)-1); 
end 
 
function result = beta_m(V) 
    result = 4*exp(V/18); 
end 
 
function result = alpha_h(V) 
    result = 0.07*exp(V/20); 
end 
 
function result = beta_h(V) 
    result = 1/(exp((V+30)/10)+1); 
end 
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c. EFFECT OF MAGNETIC FIELDS ON T-R TRANSITION DYNAMICS 
OF HEMOGLOBIN DEOXYGENATION 
 
INTRODUCTION 
Our recent results demonstrating an increase in the rate of human hemoglobin 
(Hb) deoxygenation due to nonthermal EMF exposures [Muehsam et al., 2013], 
are in accord with earlier reports of EMF-induced enhanced in vitro [Mousavy et 
al., 2009] and in vivo [Milweski et al., 2006] deoxygenation. While the specific 
transduction site(s) for the magnetic field remain unclear, our results [Muehsam et 
al., 2013] show that EMF treatment reduces the time to deoxygenate. Although 
the possible mechanisms of EMF transduction by proteins remains unknown, 
some speculation has suggested that ‘nonthermal’ pulsed radiofrequency (PRF) 
field, for which negligible heating occurs over a low duty cycle, produce transient 
heating that can alter protein conformation [Laurence et al., 2000] and that protein 
structural rearrangements not related to temperature [Porcelli et al., 1997] can 
occur under nonthermal PRF exposure. Regarding magnetic field effects, the para- 
and dia-magnetic properties of Hb have been known for some time [Pauling et al., 
1936; Pauling, 1977], but, as mentioned in a previous Chapter, no clear model 
currently exists describing magnetic field effects on Hb protein conformation or 
affinity for oxygen.  
 
Transition from the high O2 affinity relaxed (R), oxygenated state to the low O2 
affinity tense (T), deoxygenated state occurs as oxygen is delivered by Hb. 
Although this process is fundamentally dependent upon pH and O2 saturation, 
subthermal molecular motions that govern Hb allosteric behaviors have been 
described using dynamical systems techniques [Yonetani et al., 2008; Eaton et al., 
1991, 1999, Frauenfelder et al., 1991, 2003, 2009; Bellelli, 2010, Miele et al., 
2012]. Also, the Hb molecule undergoes spontaneous T-->R quaternary 
transitions of the Hb tetramer [Hub et al., 2010], indicating that these states exist 
in equilibrium with each other. An example of the potential energy V(rc) as a 
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function of reaction coordinate rc with subthermal states through which system 
passes prior to deoxygenation is shown in Figure 1, left hand plot, taken from 
Frauenfelder et al., 1991. Here, several subthermal states border the final R-T 
transition, and one transition state corresponding to the R2 liganded substate. 
Because experimental results consist of measurement of two states (the oxy-deoxy 
transition) a two-state model is considered here to describe subthermal oscillations 
for EMF effects.  
 
 
MAGNETIC FIELD EFFECTS ON HEMOGLOBIN DEOXYGENATION 
Here, the model describes the effects of an static magnetic field (MF) on an 
ongoing process of Hb deoxygenation (e.g. induced using dithiothreitol, changes 
in pH, oxygen saturation, etc.) via a modulation of the potential energy function 
for the R-T transition. Thus, a two-state model is considered to describe the 
passage between two subthermal protein conformations, one with high oxygen 
affinity and one with low oxygen affinity. Figure 1, right hand plot, shows V(rc) 
using a quartic potential to characterize the system as a double-well oscillator with 
a MF-sensitive subthermal potential energy barrier between two conformational 
states with different probabilities for the T and R states [Gammaitoni et al., 1989, 
1998]: 
 
    
V(r )  a1
rc4
4
a2
rc2
2
J (EMF)     (1) 
 
where a1 and a2 are arbitrary constants, and J (EMF)is a scalar function of the 
EMF exposure, yielding a bias in favor of the low-affinity state. 
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Figure 1. Left: Potential energy landscape for Hb oxy/deoxy transition, showing 
subthermal conformational states through which system passes en route to 
deoxygenated state (from Fraunfelder et al., 1991). Right: Passage between MF-
sensitive subthermal conformations favoring Hb T and R states is described using 
a dynamical system represented by a bistable quartic oscillator (Eqn 1). Model 
based upon MF transduction modulation of dynamics of protein hydration 
governing R-T transitions via Lorentz model (see previous Chapter).  
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Letting the dynamical motion be driven by thermal noise forces Fn, and subject to 
viscous damping G, the equation of motion is thus [Neiman et al., 1994] 
 
d2rc
dt2
G drc
dt
 dV
drc
 Fn ,    (2) 
 
which may be solved numerically [Gammaitoni et al., 1998]. 
 
Simulations were carried out using Matlab software (code shown in Appendix) 
using appropriate values for physical constants yielding stable solutions in a 
region free of bifurcations [Pilla et al., 1997]. Following on the results of previous 
chapters, (MF) here primary MF transduction is describe using the Lorentz model, 
resulting in a rotation at the Larmor frequency of waters of hydration that 
determine Hb allosteric behavior, and that the measure of reactivity is dependent 
upon the hydration orientation angle at the protein surface. Thus J (EMF)= 
Josin(ZLt) where Jo is an appropriate constant and ZL is the Larmor frequency. 
Because there are several arbitrary constants determining numerical predictions 
for the model, all results are given as normalized values. Integrating Equation 2, 
the results yield a chaotic interwell hopping of the reaction coordinate, as shown 
in Figure 2 for a simulation over 50,000 time units. Figure 2, left, top plot, shows 
that the reaction coordinate undergoes chaotic interwell hopping between high- 
and low-affinity states, computed here for MF = 0. Figure 2, left, top plot, shows 
the phase-plane diagram of these rc dynamics.  
 
Letting the Gibbs free energy for the R-T transition be proportional to the 
fractional change in the time spent in the low-affinity and high-affinity states, 
 
'G  go
tT  tR
tR
§
©
¨
·
¹
¸
     
(3) 
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where go is an appropriate constant, the rate constant k for the steady-state rate of 
deoxygenation takes the form: 
 
k { exp 'G
kT
§
©¨
·
¹¸  exp
exp
go
tTtR
tR
§
©
¨
·
¹
¸
kT
§
©
¨
¨
¨
·
¹
¸
¸
¸
.    (4) 
 
Deoxygenation as a function of Gibbs free energy from Equations 3 and 4 is 
shown in Figure 2, right hand plot. The rate constant k is weakly correlated with 
increasing magnetic field strength, due to a trend towards increasing ratio of tT/tR 
(r2 = 0.14) within the regime for which system dynamics remain chaotic, i.e. no 
bifurcations occur. Thus, the MF-exposed state exhibits lower oxygen affinity 
than the ambient only state. 
 
 
Figure 2. Left, top: Chaotic hopping of the reaction coordinate between high- 
and low-affinity states. Reaction coordinate rc as a function of time for at MF = 0. 
Left, bottom: Phase plane diagram of rc dynamics, shows that rc undergoes 
oscillatory motion between high- and low-affinity states. Right: Reaction constant 
via Eqn. 4 determined by Gibbs free energy EMF amplitude for MF exposure. 
Reaction rate is weakly correlated with increasing MF strength (r2 = 0.14) 
revealing trend towards more rapid deoxygenation under MF exposure.  
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DISCUSSION AND CONCLUSIONS 
The potential energy function used in Equation 1 has been widely studied in the 
context of stochastic resonance and bifurcation to/from chaos [Gammaitoni et al., 
1989, 1998] and we have previously applied it to MF effects on ion binding 
processes [Pilla et al., 1997]. However, because it is currently possible to 
determine the precise values of arbitrary constants that determine the exact 
location of bifurcations, here the statistics of dynamics are analyzed in a regime 
with consistent chaotic dynamics. Statistics of the motion are interpreted as a 
modulation of the Gibbs free energy for deoxygenation, yielding a relationship 
between steady-state reaction rate and the behavior of the dynamical system. As 
the MF alters the potential energy function, dynamics are gradually biased 
towards a more rapid rate of deoxygenation. The model suggests that modulation 
of known subthermal dynamics of Hb could act to yield recent results found for 
EMF exposures [Muehsam et al., 2013; Mousavy et al., 2009; Milweski et al., 
2006]. While the model presented here produces results generated by the 
assumptions underlying the MF dependence of the potential energy function, these 
assumptions do yield some information regarding the stochastic nature of the 
deoxygenation process. For example, the MF sensitivity shown in Figure 2, right 
hand plot is indicated by a weakly-correlated trend rather than a deterministic 
dependence of trajectory upon field strength. As a result, the dynamics may more 
closely reflect actual process occurring in the supra-quantum regime, where 
classical approximations to molecular motions may be applied [Binhi et al., 2003]. 
The chaotic nature of the results also suggests a sensitivity to small changes in 
initial conditions [Lorenz, 1963], such as those that could occur due to 
fluctuations in temperature, pH, oxygen saturation, gaseous environment, 
exposure to UV/visible light, the flapping of butterfly wings [Hilborn, 2004], etc, 
perhaps shedding light upon the difficulties in independent replication have 
confounded research into nonthermal EMF bioeffects [Pickard, 1995; Berg, 1999; 
Gustavsson et al., 1999; Vijayalaxmi et al., 2005]. 
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APPENDIX: MATLAB CODE FOR MAGNETIC FIELD EFFECT ON T-R 
TRANSITION DYNAMICS OF HEMOGLOBIN DEOXYGENATION 
 
load tnoise.dat 
global B0 B1 tnoise tf humpf w gammma q; 
clear ave time freq reso field crossings G;  
gammma=1.1; %1.1 %scaling driving force 
w=1; %AC frequency 
%humpsize=  2.0; 2.62 
humpsize=.9; %starting oscillator bias 
humpf=humpsize;%2.9; 
 
t0=0; tf=100; 
 
x0=[0 0]; %Initial condition: stationary at oxy setpoint 
B0=0; B1=0; 
 
%top=15; %ll-loop: 
 
numb=500; 
 
  %j-loop: increasing magnetic field. 
 field=zeros(1,numb);  %variation in DC field strength. 
 speed=zeros(1,numb);  %holder for velocity data. 
 freq=zeros(1,numb);  %variation in AC frequency. 
 time=zeros(1,numb);  %time free/bound. 
 %loudness=zeros(1,numb);  %variation in gammma (noise).  
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 %reso=zeros(numb,top);  %tf/tb for AC peak. 
 bias=zeros(1,numb);  %variation in humpf. 
%for ll=1:top;ll 
 
for j=1:numb; 
%j 
  
options=odeset('AbsTol',1e-2); 
[t,x]=ode23('duffing',[t0 tf],x0,options); 
 
 % modulation via field amplitude: 
        B0=B0+humpsize/numb; 
   % humpf=humpf-humpsize/numb 
   % humpf=humpf-1.125*humpsize/numb; 
        humpf=humpf-1*humpsize/numb; 
      %gammma=gammma+5/numb; 
       %w=w+0.5*(2*pi)/numb; 
humpf 
thi=0;tlo=0; 
 
 for k=1:length(t)-1 
  if x(k,1)<0  
  tlo=tlo+(t(k+1,1)-t(k,1)); 
  else 
  thi=thi+(t(k+1,1)-t(k,1)); 
  end% (if statement) 
 end %(k loop) 
  
%time=thi/tlo 
 loudness(j)=gammma; 
 time(1,j)=(thi-tlo);%/tlo; 
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    G(1,j)=(thi-tlo)/tlo; 
    bound(j)=tlo;unbound(j)=thi; 
 freq(j)=w/(2*pi); 
 field(j)=B0; 
 bias(1,j)=humpf; 
 speed(1,j)=mean(abs(x(:,2))); 
 
subplot(3,1,1); plot(t,x(:,1)) 
subplot(3,1,2); plot(x(:,1),x(:,2))   
%subplot(2,1,2); plot(t,x(:,1)) 
 
Yn=fft(x(:,1),2048); % Fourier spectrum subroutine 
nn=length(Yn); 
Pyy=abs(Yn); 
fr=(0:length(Yn)-1)'*1000/length(Yn); 
%semilogx(fr(1:length(Pyy)/2),Pyy(1:length(Pyy)/2)) 
Pyy=.5*Pyy(1:length(Pyy)/2); 
fr=fr(1:length(Pyy)/2); 
 
subplot(3,1,3); 
plot(fr(1:length(Pyy)/2),Pyy(1:length(Pyy)/2)) 
axis([0 200 0 600]); 
%plot(x) 
 
%subplot(3,1,3); plot(t,cos(w*t)) 
pause(.1) 
%duffzero 
%crossings(j)=q; 
end %(j loop) 
clf 
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%subplot(2,1,1);  
plot(field,time) 
%subplot(2,1,2); plot(field,-exp(time)) 
%plot(field,time) 
%reso(:,ll)=time'; 
%end %(ll loop) 
 
duffing.m 
function xdot=duffing(t,x) 
global B0 B1 tf w gammma tnoise star humpf w; 
beta=0; 
 %gammma=1; 
 %w=15;%1.26; 
a1=1; 
a2=1; 
star=ceil((t/tf)*length(tnoise)+.01); %normalizing noise signal 
 if star>length(tnoise) 
 star=abs(ceil(.1*randn*(t/tf)*length(tnoise)+.01)); 
 end 
%NOISE=0; 
NOISE=gammma*tnoise(star); 
 %harrumpf=-humpf*x(1) 
 
 
xdot=[x(2);-beta*x(2)+a1*x(1)-a2*(x(1).^3)-humpf*cos(w*t)];%adding AC field 
%xdot=[x(2);-beta*x(2)+a1*x(1)-a2*(x(1).^3)+NOISE-humpf];%Static 
perturbation 
%xdot=[x(2);-beta*x(2)+a1*x(1)-a2*(x(1).^3)+NOISE-humpf*cos(w*t)];%Noise 
+ AC field 
 
%xdot=[x(2);-beta*x(2)+a1*x(1)-a2*(x(1).^3)+NOISE-humpf*abs(B0)]; 
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%xdot=[x(2);-beta*x(2)+a1*x(1)-a2*(x(1).^3)-humpf];%Static perturbation no 
noise 
% 
%t/tf
